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1 RIASSUNTO 
 
La Retinite Pigmentosa (RP) comprende una famiglia di degenerazioni 
ereditarie eterogenee (Kennan et al. 2005) (Paskowitz et al. 2006) 
caratterizzate dall’iniziale morte apoptotica dei bastoncelli, con sviluppo di 
insufficiente capacità visiva in condizioni di scarsa luminosità e progressivo 
restringimento concentrico del campo visivo, cui segue la degenerazione dei 
coni che comporta il declino dell’acuità visiva, fino alla cecità. Sebbene la 
causa primaria della RP sia tipicamente un difetto di un gene specifico dei 
bastoncelli, la degenerazione di queste cellule attiva una cascata di eventi che 
portano sia alla morte secondaria dei coni che al cosiddetto “remodeling” 
progressivo dei neuroni della retina interna (Marc et al. 2003). Nella patologia 
umana come nei suoi modelli animali, questi eventi seguono un pattern 
spazialmente irregolare sulla superficie retinica, rendendo difficile un’analisi 
quantitativa della sopravvivenza e della morte cellulare.  
 Lo scopo principale di questa tesi è quello di far luce sugli effetti 
precoci e tardivi dell’applicazione del paradigma sperimentale 
dell’Arricchimento Ambientale (AA) sulla degenerazione dei bastoncelli, 
sulla sopravvivenza dei coni e sulla morfologia dei neuroni interni della retina 
del mutante rd10, un modello murino di RP caratterizzato dalla progressiva 
degenerazione dei fotorecettori retinici secondo un pattern simile a quello che 
avviene nell’uomo affetto da analoghe mutazioni. L’AA è un paradigma di 
stimolazione motoria, sensoriale e sociale ampiamente usato come strategia 
non invasiva di neuroprotezione in diversi modelli di patologie neurologiche, 
incluse la malattia di Alzheimer e la malattia di Huntington. In questa tesi 
vengono riportati per la prima volta i risultati dell’esposizione prolungata di 
topi rd10 ad AA.  
 Attraverso studi di microscopia del tessuto retinico, registrazioni 
elettroretinografiche, test comportamentali e analisi molecolari, viene 
mostrato che l’AA dalla nascita è in grado di preservare in modo 
 1
considerevole la morfologia, la fisiologia dei fotorecettori e la percezione 
visiva negli animali rd10. Studi preliminari suggeriscono che l’effetto 
protettivo dell’AA possa essere mediato da fattori neurotrofici, tra i quali il 
CNTF. 
 Questi risultati possono incoraggiare lo sviluppo di nuove strategie 
applicative in cui la stimolazione ambientale, da sola o in combinazione con 
opportuni trattamenti farmacologici, può promuovere la conservazione e 
l’integrità funzionale dei neuroni retinici.  
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2 ABSTRACT 
 
Retinitis pigmentosa (RP) is a family of inherited disorders leading to 
progressive photoreceptor death and is one of the major causes of genetic 
blindness in the world with no cure yet (Kennan et al. 2005) (Paskowitz et al. 
2006). In typical RP, first rods die out, as usual for a mutation in rod-specific 
genes, and night blindness occurs. Later, secondary degeneration of cones 
follows until all the useful sight is lost. Both in human RP and in animal 
models of this disease, photoreceptor death is accompanied and followed by 
gradual remodeling of the inner retina. Both photoreceptor degeneration and 
secondary remodeling of the inner retina occur with an irregular pattern over 
the retinal surface, making quantitative analysis of survival and death 
difficult.  
 The general aim of this Thesis is investigate the early and late effects of 
an Environmental Enriched paradigm upon rod degeneration and viability of 
cones and inner retinal neurons in a mouse model of RP. Environmental 
enrichment (EE), a neuroprotective strategy based on enhanced motor, 
sensory and social stimulation, has already been shown to exert beneficial 
effects in animal models of various neurological disorders, including 
Alzheimer and Huntington disease. Here, I report the results of a prolonged 
exposure of rd10 mice, a mutant strain undergoing progressive photoreceptor 
degeneration and used to model human RP, to such an enriched environment 
from birth.  
 By means of microscopic examination of retinal tissue, 
electrophysiological recordings, visual behavior assessment and molecular 
analysis, I show that EE considerably preserves retinal morphology and 
physiology as well as visual perception over time in rd10 mutant mice. The 
protective effects of EE are likely mediated by increased production of 
endogenous protective molecules, including CNTF.  
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 The therapeutic option I applied in this Thesis produced strikingly 
positive results, also in comparison to other strategies applied to the same 
animal model. This work opens the exciting possibility that non invasive 
manipulations of the outer environment can be used, alone or in combination 
with other treatemtns, to prolong the lifespan of retinal neurons otherwise 
doomed to death.  
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3 INTRODUCTION AND AIMS OF THE THESIS 
 
The mature vertebrate retina consists of five neural cell types that have 
common specializations throughout species. 
 Photoreceptors are the neurons containing the light-sensitive photo 
pigment that captures light. These cells pass the information through the 
entire retina that encodes spatio-temporal and chromatic information 
transmitted to other parts of the visual processing centers. The basic retina 
anatomo-physiology involves two kinds of circuitry: the vertical or “through” 
pathway, which includes photoreceptors, bipolar cells and ganglion cells, and 
the horizontal or “lateral” pathway, which is made by horizontal cells and 
amacrine cells. In the mammalian rod pathway, some subtypes of amacrine 
cells have a function similar to bipolar cells.  
 At first look, the spatial arrangement of retinal layers seems counter-
intuitive, because light rays have to pass through various non-light-sensitive 
elements of the retina as well as the retinal vasculature before reaching the 
outer segments of the photoreceptors, where photons are absorbed. The reason 
of this curious feature of retinal organization lies in the special relationship 
that exists among the outer segments of the photoreceptors, the pigment 
epithelium, and the underlying choroid. The disks present in the photoreceptor 
outer segments are formed near the inner segment of the photoreceptor and 
move toward the tip of the outer segment, where they are shed. The pigment 
epithelium plays an essential role in removing the exhausted receptor disks. In 
addition, the pigment epithelium contains the biochemical machinery that is 
required to regenerate photo pigment molecules after they have been exposed 
to light. Finally, the capillaries in the choroid underlying the pigment 
epithelium are the primary source of sustenance for retinal photoreceptors.  
These functional considerations explain why rods and cones are found in the 
outermost rather than in the innermost layer of the retina. They also explain 
why disruptions in the normal relationships between the choroids, pigment 
 5
epithelium and retinal photoreceptors, such as those that occur in some forms 
of Retinitis pigmentosa, have severe consequences for vision. 
 Retinitis pigmentosa (RP) refers to a heterogeneous group of hereditary 
retinal disorders characterized by progressive vision loss due to a gradual 
degeneration of photoreceptors. An estimated 100,000 people in the United 
States have RP. In spite of the name, inflammation is not a prominent part of 
the disease process; instead the photoreceptor cells appear to die by apoptosis 
(determined by the presence of DNA fragmentation). Multiple mutations have 
been found, and the heterogeneity of RP at all levels, from genetic mutations 
to clinical symptoms, has important implications for understanding the 
pathogenesis of the disease and designing therapies. 
 Given the complex molecular etiology of RP, it is unlikely that a single 
cellular mechanism will explain the disease in all cases. Despite the specific 
mutation or causal sequence, the major vision loss in RP patients is due to the 
gradual degeneration of cones. Typically, the mutated protein causing RP is 
not expressed in cones and the loss of these cells is an indirect result of a rod-
specific mutation. Hence, understanding and treating this disease presents 
particularly difficult challenges. Recently, there is increasing excitement 
about the possibility of using gene therapy to substitute the rod defecting 
gene, and multiple groups are developing vectors encoding growth factors 
(Schlichtenbrede et al. 2003; Yang 2009) or antioxidant enzymes (Li et al. 
2008; Koilkonda and Guy 2011) to retard the secondary loss of 
photoreceptors due to a lack of tropic factor or an excessive oxidative stress. 
There are also other therapeutic strategies under development, such as the 
optogenetic and the stem cell approaches, or the use of nanoparticles to 
deliver genes or proteins (Berson et al. 1993; Busskamp and Roska 2011). 
The endurance of these experimental designs and their effective applicability 
to RP will certainly be tested in the near future. It is important to recall that 
combinations of approaches are likely to be more powerful than any 
individual treatment (Yao et al. 2011). 
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 The main aim of the present Thesis was to investigate the non invasive 
approach of Enviromental Enrichment (EE) as a strategy to retard the 
secondary loss of cones in a well known mouse model of RP, the r10 mutant 
mouse. The rationale is that it is well known that through sensory, cognitive 
and motor stimulation it is possible to enhance the capability of the central 
nervous system to respond to different pathological conditions 
(Nithianantharajah and Hannan 2006; Baroncelli et al. 2010). 
The working hypothesis is that EE, a paradigm whereby the animals are 
raised and kept in large cages and social groups with additional toys 
specifically devoted to multi-sensory, cognitive and motor stimulation, can 
retard the secondary events due to the loss of rod photoreceptors in rd10 
mutant mice, delaying the degeneration of cones. To test this hypothesis, rd10 
mutant mice were kept and grown in either EE conditions or in Standard 
laboratory (ST) conditions from birth.  
 More specifically, in this Thesis we focused on two specific aims: 
Aim 1: to asses morphological, molecular and functional effects of EE in 
adult rd10 mutant mice.  
To achieve this aim we: 
• Compared retinal morphology in ST mice and EE mice using 
quantitative immunostochemistry to analyze in detail photoreceptor 
morphology and number, as well as the morphology of the inner retina. 
• Compared the expression of photoreceptor specific proteins by means 
of western blot analysis. 
• Compared the viability of photoreceptors by means of 
electroretinogram (ERG) recordings.  
• Compared the visual performance of mice by means of a visual 
behavioral test used to measure both visual acuity and contrast 
sensitivity.  
• Compared the expression of different trophic factor mRNAs by means 
of Real Time RT-PCR in ST and EE retinas. 
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 Aim 2: to assess the long run beneficial effects of EE in 1 year old rd10 
mutant mice.  
To achieve this aim we: 
• Compared retinal morphology in ST and EE mice using 
immunostaining techniques to analyze photoreceptor morphology and 
number in the inner retina. 
• Compared the visual performance of mice by means of a visual 
behavioral test used to measure both visual acuity and contrast 
sensitivity. 
 
3.1 The retina 
3.1.1 Anatomical organization of the retina 
 
The eye is a sphere filled of fluid surrounded by three layers of tissue. The 
inner layer of the eye, the retina, contains neurons that are sensitive to light 
and are capable of transmitting visual signals to central targets. Despite its 
peripheral location, the retina is part of the central nervous system (CNS). 
During the embryonic development, the vertebrate retina and the optic nerve 
form as an out pocketing of the diencephalon, called the optic vesicle, which 
invaginates forming the optic cup. The inner coat of the optic cup gives rise to 
the retina, while the outer one gives rise to the retinal pigment epithelium. 
This is a thin melanin-containing layer that reduces backscattering of light 
that enters in the eye; it also plays a critical role in the maintenance of 
photoreceptors, renewing photo pigments and phagocyting the photoreceptor 
disks.  
 Compared to other portions of the CNS, the retina comprises fewer 
classes of neurons, and these are arranged in a manner that has been less 
difficult to unravel than the circuits in other areas of the brain. There are, at 
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all, five major classes of retinal neurons: photoreceptors, bipolar cells, 
horizontal cells, amacrine cells and ganglion cells. In the adult retina, these 
are organized into three main cell body layers that are separated by synaptic 
terminals (plexiform layers) (Fig. 1). Light passes through the lens and across 
the whole retinal thickness to stimulate photopigments in the outer segments 
of rod and cone photoreceptors, which are located adjacent to the Retinal 
Pigment Epitelium (RPE). The photoreceptors, whose cell bodies costitute the 
outer nuclear layer (ONL), form synapses in the outer plexiform layer (OPL) 
with horizontal cells and bipolar neurons, whose cell bodies are located in the 
inner nuclear layer (INL). Bipolar cells synapse directly or indirectly via 
amacrine neurons in the inner plexiform (IPL) layer to ganglion cells (GCs) 
located in the GC layer. GCs are the projection neurons of the retina and 
transmit visual information via their axons through the optic nerve to visual 
processing centers in the brain. Amacrine cell bodies are located in the inner 
part of the INL and comprise roughly half of the cells in the GC layer. The 
retina also contains a population of radial glial cells called Muller glia, whose 
cell bodies are located in the INL. Their apical processes form adherents 
junctions with photoreceptors at the outer limiting membrane and their end 
feets attach to the basal lamina on the vitreal surface of the retina at the inner 
limiting membrane. Retinal astrocytes, which develop from a separate cell 
lineage at the optic disc, form a dense network on the vitreal surface of the 
retina and are closely associated with the vasculature. Microglial cells, of 
mesodermal origin, also reside permanently in the retina. 
 The combination of highly specialized cell types in well-organized 
networks performing complex modulatory activities results in an amazing and 
flexible sensory processing system and makes the retina a unique model for 
the comprehension of the relationship between structure and function inside 
the CNS. 
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Fig. 1. Structure of the retina. (A) Section of the retina showing the overall arrangement of 
retinal layers. (B) Diagram of the basic circuitry of the retina. A three-neuron chain 
photoreceptor, bipolar cell, and ganglion cell provides the most direct route for 
transmitting visual information to the brain. Horizontal cells and amacrine cells mediate 
lateral interactions in the outer and inner plexiform layers, respectively. The terms inner 
and outer designate relative distances from the center of the eye (inner, near the center of 
the eye; outer, away from the center, or toward the pigment epithelium). From Purves 3ed 
2004. 
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3.2 The architecture of the mouse retina 
The mouse retina resembles that of other vertebrates, so that in a vertical 
section the following layers and cells can be recognized: 
? Photoreceptor layer: formed by the outer and inner segments of rods 
and cones; 
? Outer Limiting Membrane (OLM); 
? Outer Nuclear Layer (ONL): constituted by photoreceptor cell bodies; 
? Outer Plexiform Layer (OPL) where processes of photoreceptors, 
bipolar and horizontal cells are synaptically connected; 
? Inner Nuclear Layer (INL): formed by cell bodies of bipolar, 
horizontal, amacrine, and Müller glial cells; 
? Inner Plexiform Layer (IPL) where processes of bipolar, amacrine and 
ganglion cells synaptically connect; 
? Ganglion Cell Layer (GCL), containing the cell bodies of ganglion cells 
and displaced amacrine cells; 
? Optic nerve Fiber Layer (OFL), constituted by axonal bundles of 
ganglion cells and supporting astrocytes; 
? Inner Limiting Membrane (ILM). 
 
The fundamental plan of the mouse retina follows the blue-print common to 
all mammalians: rods represent the majority of the photoreceptor population; 
however, the mouse retina is particularly rod-dominated and rods sum up to 
97% of all the photoreceptors (Jeon et al. 1998). In the C57B16/J strain of 
mouse, used for the experiments described thereafter, there are approximately 
6.4 million rods and 180,000 cones (Eye, Retina, and visual system of the 
mouse; chapter 12).  
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Fig. 2. Schematic representation of the main connections among retinal neurons. The 
physiology of the retina can be simplified into 4 main processing stages: photoreception, 
transmission to bipolar cells, transmission to ganglion cells and transmission along the 
optic nerve. At each synaptic stage there are also laterally connecting horizontal and 
amacrine cells. 
 
 Figure 2 summarizes the main connections among retinal neurons. 
Photoreceptors - rods and cones - convert light information into electrical and 
then chemical signals relayed to inter-neurons in the outer retina. At low light 
levels, only rods have sufficient sensitivity to capture the few photons that are 
available. Cones permit day and color vision. Photoreceptors are connected to 
each other by gap junctions (electrical synapses) and make chemical synapses 
onto bipolar and horizontal cells. Two types of bipolar cells, rod and cone 
bipolars, are postsynaptic to the homologous photoreceptor populations. Cone 
bipolar cells are further divided in two functional classes, called “ON” and 
“OFF” that respectively depolarize and hyperpolarize in response to the 
illumination of their receptive field centers. Rod bipolar cells belong to the 
single functional category of ON cells. Bipolar cells are then connected to 
RGCs to the same type (ON or OFF): this connection can be direct as in the 
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case of cone bipolar cells, or through a chain of neurons comprising dedicated 
amacrine cells, as for rod bipolar cells. 
 Differently from most mammals that have at least two horizontal cell 
types, mice have only one type of horizontal cells (Peichl and Gonzalez-
Soriano 1994). Horizontal cells contribute to enhance contrast between 
adjacent light and dark regions. This is because they are constituted by two 
different, functionally distinct portions, by which they can control bipolar cell 
sensitivity: the dendritic arborization makes synapses with cones, while the 
axonal arborization is linked to rods. The connection horizontal cells - 
photoreceptors is bidirectional: not only horizontal cells are post- synaptic to 
rods, but also pre-synaptic to cones on which they exert a negative feed-back. 
Amacrine cells (more than 30 types) modulate signals from bipolar cells by 
supplying inhibition directly onto ganglion cells; moreover, they modulate 
transmitter release from bipolar cells. Light information leaves the retina and 
reaches other stations in the brain via axons of RGCs (the only exit neurons of 
the retina) that collectively form the optic nerve. The commonly employed 
C57Bl6/J mouse retina contains approximately 50,000 ganglion cells. Most of 
them project contralaterally, since their axons cross at the optic chiasm; only 
less than 5% of all ganglion cells project ipsilaterally. Beside these above 
mentioned five classes of neurons, the retina contains one type of macroglial 
cells, the Müller cells. These have a radial arrangement spanning the depth of 
the retina and provide important structural and functional support to retinal 
neurons. 
 Within the above described basic organization, many specialized sub-
circuits are present in the vertebrate retina: they work both in sequence and in 
parallel to process different features of the visual image such as luminosity, 
contrast, chromatic composition and direction of motion (Weng et al. 2005) . 
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3.2.1 Photoreceptors 
 
The two types of photoreceptors, rods and cones, are distinguished by shape 
(from which they derive their names), the type of photo pigment they contain, 
the distribution across the retina, and the pattern of synaptic connections. 
These properties reflect the fact that the rod and cone systems (both the 
receptors and their connections within the retina) are specialized for different 
aspects of vision. The rod system has very low spatial resolution but is 
extremely sensitive to light; it is therefore specialized for sensitivity at the 
expense of resolution. Conversely, the cone system has very high spatial 
resolution but is relatively insensitive to light and it is specialized for acuity at 
the expense of sensitivity. The properties of the cone system allow humans 
and many other animals to see colors. The rod-mediated perception is called 
scotopic vision because at the lowest levels of light, only the rods are 
activated.  
 Although cones begin to contribute to visual perception at about the 
level of starlight, spatial discrimination at this light level is still very poor. As 
illumination increases, vision becomes more and more dominated by cones 
and they are the major determinant of perception under relatively bright 
conditions such as normal indoor lighting or sunlight. The contribution of 
rods to vision drops out nearly entirely in the so called photopic vision, 
because their response to light saturates. This means that the membrane 
potential of individual rods no longer varies as a function of illumination 
because all of the light-sensitive channels are closed. Mesopic vision occurs 
in levels of light at which both rods and cones contribute, for example at 
twilight.  
 The ability of rods and cones to respond to different ranges of the light 
absorption spectrum is due to differences in their photo pigments. The 
spectral sensitivity of mouse rod photoreceptors peaks at 497-500nm (Soucy 
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et al. 1998; Toda et al. 1999; Fan et al. 2005). In the mouse retina, there are 
two types of cone photoreceptors: one has peak sensitivity at 360nm (UV 
light), while the other has peak sensitivity at 508 nm ((M)-wavelength). Most 
cones express both UV and M photopigments but their maximum sensitivity 
is at 508 nm (Nikonov et al. 2006). Another difference between the two types 
of photoreceptors is their sensitivity to light intensity. Rods produce a reliable 
response to a single photon of light, whereas more than 100 photons are 
required to produce a comparable response in a cone (Eye, Retina and visual 
system of the mouse; chapter 12). Also, the response of an individual cone 
does not saturate at high levels of steady illumination, as does the rod 
response. Although both rods and cones adapt to operate over a range of 
luminance values, the adaptation mechanisms of cones are more effective. 
This difference is apparent in the time course of the response of rods and 
cones to light flashes. The response of a cone, even to a bright light flash that 
produces the maximum change in photoreceptor current, recovers in about 
500 milliseconds, more than four times faster than rod recovery.  
 The arrangement of the circuits that transmit rod and cone information 
to retinal ganglion cells also contributes to the different characteristics of 
scotopic and photopic vision. In most parts of the retina, rod and cone signals 
converge on the same ganglion cells; i.e., individual ganglion cells respond to 
both rod and cone inputs, depending on the level of illumination. The early 
stages of the pathways that link rods and cones to ganglion cells, however, are 
largely independent. The pathway from rods to ganglion cells involves a 
distinct class of bipolar cell (rod bipolar) that, unlike cone bipolar cells, does 
not contact retinal ganglion cells. Rod bipolar cells synapse with the dendritic 
processes of a specific type of amacrine cell (the AII amacrine) that makes 
gap junctions and chemical synapses with the terminals of cone bipolars; 
these processes, in turn, make synaptic contacts on the dendrites of ganglion 
cells in the IPL. As a consequence, the circuits linking the rods and cones to 
retinal ganglion cells differ a) in the number of interposed neurons and b) in 
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their degree of convergence. Each rod bipolar cell is contacted by a large 
number of rods, and many rod bipolar cells contact a given amacrine cell. In 
contrast, the cone system is much less convergent and thus less sensitive. 
 
3.3 Genetics 
 
3.3.1 Genetic mutations affecting photoreceptors 
 
A very high number of genetic mutations affect the eye. Those occurring in 
photoreceptor- or pigment epithelium -specific genes often cause Retinal 
Degenerations (RDs), a family of inherited dystrophies characterized by 
photoreceptor dysfunction and death. It is estimated that more than 15 million 
people worldwide have vision loss due to inherited forms of RD. These 
include patients suffering from Retinitis pigmentosa (RP), a disease for which 
there is no cure yet (Chader 2002). 
 
3.3.2 Retinitis pigmentosa (RP)  
 
One of the common subtypes of inherited forms of photoreceptors 
degeneration is Retinitis pigmentosa (RP), which is the second main cause of 
blindness in 20-64 years olds (Wright et al. 2010). RP represents an 
heterogeneous group of genetic disorders that lead to loss of vision. Typically, 
rods, the first cells affected, start to die (as a result of a genetic abnormality) 
and patients experience night-vision limitations and develop visual field 
constriction (or tunnel vision) (Fig. 3d). Secondary cone degeneration 
eventually affects central vision, leading to blindness. RP cause severe visual 
impairment in as many as 1.5 million patients worldwide (Kennan et al. 2005; 
Mendes et al. 2005) (Paskowitz et al. 2006). 
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Fig. 3. Typical examples of night blindness (b) and tunnel vision (d). This is a typical 
example of eye field degradation in RP patients. Normal night vision (a) and a normal day 
vision (c) in human. 
 
The progressive demise of photoreceptors also precipitates other pathological 
symptoms in the retina, including the attenuation of the retinal vasculature 
and the accumulation of intra-retinal pigment deposits, from which the 
disease derives its name (Fig. 4). 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Example of fundus views of the retina of a RP patient. A typical brown 
pigmentation is present in the pathological condition. Pigment deposits, named bone 
spicules for their typical shape, are responsible for the name of the disease. A clear 
attenuation of retinal blood vessels is also visible. From:Web Vision. 
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 There is considerable variation in the severity of the conditions of the 
RP patients: it is unusual for them to become totally blind, while most of them 
retain some useful vision well into old ages. Classic clinical findings of RP 
include: bone spicule pigmentation or pigment clumping, retinal arteriolar 
narrowing, waxy pallor of the optic nerve, epiretinal membrane formation, 
atrophy of the RPE and choriocapillaris (starting at the mid periphery of the 
retina with preservation of the RPE in the macula until late in the disease), 
posterior subcapsular cataract, epiretinal membrane formation, and cystoid 
macular edema (CME) (Hamel 2006). 
 
3.3.3 Genetics and molecular mechanisms of RP  
 
The genetics of RP is complex: approximately 180 mutations in more than 40 
genes have been identified as the cause of different forms of RP. In a 
segregation analysis of RP, families were divided as autosomal dominant 
(24%), autosomal recessive (41%) and X-linked (22%), and the remaining 
12% of cases were supposed to result from non-genetic factors, non-
Mendelian inheritance (for example, mitochondrial or de novo mutations) or 
complex inheritance (Wright et al. 2010). The large number of mutations 
causing RP comprise insertions, deletions, or substitutions, in turn producing 
missense mutations or truncations (Wang et al. 2005). RP is caused 
preferentially by different single gene mutations including the following: 
GTPase regulator (RPGR: 10-20% of cases) rodopsin (RHO: 8-10% of cases) 
and usherin (USH2A: ≈3% of cases) (Jos´e M. Mill´an and Ascensi ´on 
Gimenez-Pardo 2011). Some of these genes encode for proteins of the 
phototransduction pathway, or play a role in the maintenance of cellular 
structure or in the transcriptional control of other photoreceptor genes 
(Kennan et al. 2005; Mendes et al. 2005). 
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Here I will describe one mutation of the phototransduction cascade: the Pdeb 
mutation that might cause autosomal recessive RP (arRP) and is also carried 
by the mouse model used in this study. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Phototransduction activation. The enzyme phosphodiesterase (Pde) comprises 
different subunits (alpha, beta, gamma and delta). Mutations in each of these subunits can 
lead to RP. From: Wikipedia. 
 19
3.3.4 Pdeb mutations and the rd10 mutant mouse 
 
For over 30 years, the retina of rodents has provided an invaluable tool to 
study the dynamics and mechanisms of inherited RD, as mouse 
photoreceptors undergo dystrophies caused by spontaneous DNA mutations, 
closely related to those of humans. The so-called rod-less mice (Keeler 1924) 
expresses a nonsense mutation in the Pdeb gene coding for the β-subunit of 
cGMP phosphodiesterase of rods. This spontaneous mutation later named rd1 
(rd1: Pde6brd1) (Pittler et al. 1993) was subsequently found in humans with 
arRP (McLaughlin et al. 1993; McLaughlin et al. 1995) and had forms of 
night blindness (Gal et al. 1994). 
There is a surprisingly high degree of evolutionary stability for mutations that 
cause loss of vision in mice, in fact many of the commonly used inbred 
strains, including C3H and its derivatives and CBA/J, are homozygous for 
rd1. In particular, two mutations in the Pdeb gene of rd1 mice have been 
identified: besides the nonsense mutation that causes truncation of the protein 
(Bowes et al. 1990), the intronic insertion of an endogenous mouse leukemia 
virus (Xmv28) causes an incorrect splicing. Xmv28 has also been found in 
strains derived from wild type mice, as well as from inbred laboratory strains 
not known to have recent common origins (Bowes et al. 1993). Evidently, 
there is little or no selective pressure to maintain a functional β-PDE gene, 
and therefore vision, in these nocturnal animals.  
 Biochemical studies comparing retinas from normal and rd1 mice have 
show that the lack of cGMP-PDE activity causes a dramatic increase in 
cytoplasmic cGMP concentration (Farber and Lolley 1974). The Pdeb gene-
triggered cell death alters the expression of genes involved in diverse cellular 
pathways including Ca2+ homeostasis, catabolism, neuro-inflammation and 
tissue remodeling (as the blood-retina barrier undergoes a breakdown). In 
mouse photoreceptors, normal Ca2+ levels range between ~250 nmol/liter (in 
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complete darkness) and ~60 nmol/liter (in light) (Woodruff et al. 2002). 
However, in the rd1 photoreceptors, Ca2+ levels are increased up to ~190% 
over wt levels (Fox et al. 1999). Consequently, messages for Ca2+-binding 
proteins, and in particular Ca2+ sensors such as calbindin, are up-regulated in 
the rd1 photoreceptors. So far, the focus has been on Ca2+ as major trigger of 
the apoptosis cascade, while the role of high cGMP levels remains 
unanswered yet.  
 The animal model we used for our studies is another example of 
autosomic recessive RP, isolated at the Jackson Laboratories in the USA 
(Chang et al. 2002), and namely the rd10 (retinal degeneration 10) mouse. 
Genetic analysis shows that this strain carries an autosomal recessive 
mutation that maps to mouse chromosome (Chr) 5. Sequence analysis shows 
that the retinal degeneration is caused by a missense point mutation in exon 
13 in the Pde6b gene of the β-subunit of the rod cGMP phosphodiesterase (β-
PDE) gene (Pde6b). The mutation changes codon 560 from CGC to TGC 
resulting into an arginine to a cysteine change and in the loss of a CfoI site. 
The exon 13 missense mutation is the first known occurrence of a re-mutation 
in the Pde6b gene in mice and represents an additional model for studying the 
pathogenesis of autosomal recessive RP in humans (arRP). It may also 
provide a better experimental model for RP because of its later onset and 
milder phenotype compared to the more common rd1 mutant (Otani et al. 
2004). In fact, in rd10 mutant mice, photoreceptor degeneration starts around 
P18 (about 10 days after the rd1 mutation), when retinal development is far 
more advanced. Rod death follows a central to periphery gradient; then a 
slower degeneration of cones occurs. A scattered population of aberrant cones 
persists up to at least 9 months of age. Atrophic retinal vessels are found at 
four weeks of age, consistent with retinal degeneration (Chang et al. 2007; 
Gargini et al. 2007). Electroretinograms (ERGs) of rd10 mice are never 
normal, but rod and cone ERG a- and b-waves can be measured at P18 while 
there is no more response at three months of age and later. Interestingly, 
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rearing rd10 mice in total darkness delays degeneration for at least a week, 
after which morphological and functional loss progresses irregularly (Chang 
et al. 2002). 
 As in other models of retinal degeneration (Chang et al. 1993; Reme et 
al. 1998), death of photoreceptors in rd10 mice shows the hallmarks of 
apoptosis: nuclei in the ONL are picnotic and some of them express a form of 
activated Caspase 3. Apoptotic markers appear in the retina in a centre to 
periphery gradient. 
 Secondary changes also affect inner retinal cells. Modifications in their 
morphology become detectable at around one month of age, and are more 
widespread at 2 months. Mostly, changes affect rod bipolar and horizontal 
cells. Their dendritic complement becomes progressively more scant and 
disorganized ultimately regressing completely. Cone bipolar cells follow, at a 
slower rate. Dendritic retraction in bipolar cells which carry glutamate 
mGluR6 receptors is preceded by a decrease in the immunoreactivity for this 
marker, and by its displacement to the cell bodies and bipolar cell axons in the 
INL. Morphological changes in bipolar and horizontal cells occurring in the 
rd10 retina are followed by their death partial death. Other cell types, such as 
AII and cholinergic amacrine cells, do not seem to be affected in the first 5 
months of life (Gargini et al. 2007). 
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3.4 Therapeutic Approaches 
3.4.1 Therapeutic strategies for RP 
 
At present, there is no therapy able to stop the evolution of RP or to restore 
vision loss in this disease. However, there are several therapeutic strategies 
aimed at slowing down retinal degeneration or at supplying the loss of cells in 
this tissue. 
 In general, prenatal diagnosis can be useful in families in which the 
responsible gene has been identified, particularly for early onset and severe 
forms of RP. For other cases, clinical evidence and data from animal studies 
indicate that some genetic types of RP are partly light-dependent (Wang et al. 
1997). Thus, patients with RP are recommended to wear dark glasses outdoor, 
or yellow-orange spectacles minimizing photophobia. Beside therapies aimed 
at preserving visual function and preventing cell death, researchers experience 
the tremendous challenge of trying to restore visual function. However, 
because mammalian photoreceptors are neurons and do not divide after birth, 
their loss is irreversible. In addition, the loss of photoreceptors leads to a 
dramatic remodeling of the inner retina which would probably modify the 
visual information process. Nevertheless, numerous groups are now working 
to achieve visual restoration either by photoreceptor replacement or by using 
artificial prosthesis that substitute their function. A synthesis of the most 
representative clinical or experimental strategies to treat RP is given below. 
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3.4.2 Vitaminotherapy  
 
Vitamins A and E seem to protect the photoreceptors because of their trophic 
and anti-oxidant effects, respectively. It has been shown that long term (5–12 
years) vitamin A supplementation slightly slows down the loss in ERG 
amplitude, while vitamin E seems to have adverse effects. Indeed, based on a 
study of the natural course of RP, patients who happen to be taking vitamin 
A, vitamin E, or both were recorded to have slower declines in ERG 
amplitudes than those not taking such supplements (Berson et al. 1985; 
Berson et al. 1993). This observation prompted a randomized clinical trial of 
oral vitamin A and E supplements in 601 patients with dominant, recessive, 
and X-linked non-syndromic Retinitis pigmentosa and Usher’s syndrome type 
II. Participants were randomly assigned either daily vitamin A as retinyl 
palmitate15 000 IU, vitamin E 400 IU as dl-α-tocopherol, the combination, or 
trace amounts of both vitamins; follow-up was for 4–6 years. In this study 
patients assigned high-dose of vitamin A showed a significantly slowed 
decline in cone ERG amplitudes than the other groups; however, in a 
subgroup in which the effect was higher there was also a significant negative 
effect of vitamin E. These studies are still debated: vitamin A should not be 
given to RP patients with mutations in ABCA4 (Berson et al. 1993; Berson et 
al. 1993), a gene responsible for a subset of recessive Retinitis pigmentosa. 
Other mutant alleles of ABCA4 cause related diseases, recessive cone-rod 
dystrophy, and recessive Stargardt macular degeneration. A study on abca4 (-
/-) mice indicates that vitamin A supplementation should be avoided in 
patients with ABCA4 mutations or other retinal or macular dystrophies 
associated with lipofuscin accumulation in the retinal pigment epithelium 
because it enhances this accumulation. 
 Another nutritional treatment assessed for patients with RP is based on 
docosahexaenoic acid (DHA), an omega-3 fatty acid found in high 
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concentrations in oily fish such as salmon, tuna, mackerel, herring, and 
sardines. DHA is apparently important for photoreceptor function, since 
membranes containing rodopsin and cone opsins in photoreceptor cells have 
very high concentrations of this fatty acid. In a recent study, patients were 
given docosahexaenoic acid (DHA) supplementation, in addition to vitamin 
A. It was shown that the RP degeneration of photoreceptors initially slowed 
down by the addition of DHA, but the beneficial effect did not last over 2 
years (Berson et al. 2010). 
 Recently, Clemson et al. 2011 demonstrated that the use of retinoids 
and other small molecules as pharmacological chaperones increases the yield 
of properly folded RP mutant rhodopsins in heterologous cell culture. Also 
they tested whether other known small molecules can provide similar effects. 
Valproic acid (VPA) was identified as a potent inhibitor of histone 
deacetylase (HDAC) also effective increasing the levels of various 
neurotrophic factors. VPA and its derivative, divalproex sodium, is used off-
label for a variety of indications including chronic pain syndromes, cancer 
therapy and schizophrenia. In their work Clemson et al. suggested that VPA 
may be an appropriate agent to treat patients with retinal dystrophies such as 
RP (Clemson et al. 2011). 
 
3.4.3 Pharmacological treatments 
 
Pharmacological treatments may be a good choice in those cases where some 
aspects of the pathophysiological mechanisms of RP are known. 
Pharmacological agents can compensate for a biochemical defect, and 
enhance or inhibit the activity of various effectors. Calcium-channel blockers 
have been tried in different animal models of RP (Nakazawa 2011) suggesting 
that calcium channel antagonists may inhibit photoreceptor apoptosis 
triggered by abnormally high levels of calcium. Recently an in vivo study on 
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rd10 mutant mice has demonstrated that photoreceptor loss can be slowed by 
pharmacologically inhibiting the rate limiting enzyme of the synthesis of 
ceramide, a known pro-apoptotic messenger (Strettoi et al. 2010). 
 
3.4.4 Artificial devices 
 
The development of artificial implants inserted in substitution of an entire part 
of the pathological retina represents an active line of investigation to treat 
both RP and other retinal diseases, such as macular degeneration. Micro-
photodiodes arrays replacing degenerated photoreceptors or more 
sophisticated devices capturing light and stimulating retina, optic nerve or 
visual cortex have been developed. Several clinical trials have essentially 
demonstrated the tolerance of these electronic implants (Zrenner 2002). Some 
of these approaches have already improved the eyesight of patients with 
major visual impairments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. Epiretinic implant: on a normal glasses is mounted a microcamera that supplies the 
signals, this signals are transmitted to the chip through microcable in the eyes. The chip 
gives energy to the electrodes in epiretinic space.                
From:www.forumsalute.it/community/forum_65_oculistica/thrd_149058_un_microchip_i
mpiantato_nella_retina_rida_la_speranza_chi_non_vede_1.html. 
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 Of course, retinal prostheses are only effective if the visual pathway 
distal to the retinal implant is still intact and functional (Fig. 6). Two types of 
prostheses have been developed according to the site of retinal implant: 
epiretinal (on the surface of the retina) and subretinal (between the retina and 
the RPE) prostheses (Chow et al. 2004) (Hossain et al. 2005), briefly 
illustrated below subretinal prostheses contain microphotodiodes attached to 
microelectrodes. These implants, such as the artificial silicon retina (5000 
microelectrodes), are placed in the subretinal space between the outer retina 
and retinal pigment epithelium (Fig. 6). The photodiodes are stimulated by 
light passing through the retina, and the resulting electric current excites 
adjacent retinal sensory neurons. The specifications for subretinal implants 
vary. For example, a typical device measures 50-100 µm wide, has a diameter 
of 2-3 mm, and carries microphotodiodes on a microelectrode array (Chow et 
al. 2004). These implants do not require an external electrical source as 
incident light is sufficient for stimulation (Zrenner 2002). Subretinal devices 
have been tested in animal experiments (Butterwick et al. 2009). Several 
species have shown tolerance to the implants, for up to 30 months of time. 
Histological evidence has shown no relevant changes in the architecture of the 
retina. Visual perception is improved in six human patients with RP who 
received an artificial silicon retina, including subjective improvement in 
appreciation of brightness, contrast color, movement, shape and visual field. 
Some patients show an improvement in visual acuity.  
 Two major advantages of subretinal prostheses are the utilization of 
existing forces between the neural retina and retinal pigment epithelium to 
maintain their position and the potential of a high spatial resolution, as they 
are positioned close to retinal nerve cells and can stimulate neurons by means 
of low electrical currents. The main disadvantages of subretinal implants 
include impaired nourishment of the inner retina due to the creation of a 
mechanical barrier between the outer retina and the choroid and the 
occurrence of trauma to the retina during implanting. These prostheses also 
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show poor dissipation of heat and therefore could damage the retina. The 
mechanism of action of these implants may be by direct stimulation of retinal 
neurons. A specific neurotrophic effect elicited locally onto photoreceptors by 
means of the surgical procedure cannot be excluded: a study of subretinal 
artificial silicon implants in rats showed a temporary protective effect on the 
retina, resulting in decreased degeneration of photoreceptors (Zrenner 2002).  
 Epiretinal prostheses are composed of an array of electrodes implanted 
on the surface of the retina between the vitreous and the inner limiting 
membrane. The implants receive electrical signals from a camera positioned 
outside the body (Fig. 6 for more details; see also Fig. 7, for in vivo 
application). In one such device, the camera transmits light signals to a 
microchip within the camera. This microchip deciphers the signal and relays 
it, using wireless transmission, to a microchip in the epiretinal implant which 
in turn stimulates the RGCs (Zrenner 2002). Early studies in dogs and rabbits 
showed the flexibility of using epiretinal prostheses. A few clinical trials in 
humans have reported simple visual perception as phosphenes. Perception of 
light has been only reported by three “completely blind” patients with RP who 
received the so-called “second sight” model: these implants have survived for 
up to two years. 
 
 
 
 
 
 
 
 
 
Fig. 7. Fundus photography showing an epiretinal electronic implant. 
From: www.ophthalmologytimes.com/ophthalmologytimes/articleDetail.jsp?id=140725. 
 
 
 28
 One advantage of epiretinal implants over subretinal devices is that the 
camera can process signals before they reach the implant: this allows 
optimization of the signal quality, which may lead to improved visual 
perception. Epiretinal implants can also use the heat-dissipating properties of 
the vitreous and are therefore less likely than subretinal implants to damage 
the retina. The superficial location of the implant reduces risks of trauma 
during implantation and allows for the implant to be replaced. The main 
disadvantages of epiretinal implants are the need for complicated 
microtechnology and surgical techniques that ensure secure fixation of the 
implant on the retina. The device also requires a higher electrical current than 
the subretinal implant (Lakhanpal et al. 2003). Implants are being developed 
to generate their own electrical currents on stimulation. 
 Some epiretinal prostheses used to attempt restoring sight in RP 
patients are designed to produce direct or near stimulation of RGCs. The 
success of such electronic devices is partly based upon the hope that RGCs 
are still viable after photoreceptors death. Yet, recent data show that some RP 
subjects lack phosphenes in respond to epiretinal stimulation (Delbeke et al. 
2001). In addition, it has been reported that perceptual thresholds for 
electrical activation of the retina are surprisingly high in RP patients (Rizzo 
2011). This is partially confirmed by the work of Stasheff with microelectrode 
arrays on RGCs in the rd1 mouse (Stasheff 2008). Here, RGCs have a much 
higher spontaneous frequency than normal, sometimes in rhythmic bursts 
reminiscent of epileptic discharges. A probable explanation could be that a 
strong remodeling of RGCs has occurred, and their membrane has become 
relatively less excitable to exogenous stimulation. 
 According to the group of Fishman (Stanford Nanofabrication Facility), 
all the present types of prosthetic chips (either sub or epiretinal) stimulate 
neurons electrically with limited spatial control and without cell specificity. 
For example, extracellular electrodes can excite retinal cells but cannot inhibit 
them (unlike physiological neurotransmitters such as GABA and glycine). An 
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ideal chip should deliver a chemical stimulation so that different transmitters 
are recognized by different cells and produce different, and specific, effects. 
To overcome these limits, researchers are working on the ‘‘artificial synapse 
chip”, in which the advantages of two technologies, electronic engineering 
and cell biotechnology, are combined. The prototype chip should drive 
growth of retinal cell dendrites and axons directly into the chip, essentially 
mimicking a synapse, by controlled, repeatable release of neurotransmitters, 
as occurs in natural vision (Peterman et al. 2003; Peterman et al. 2004). 
 
3.4.5 Gene therapy 
 
This therapeutic approach consists in the introduction into the retina of adeno-
associated viral vectors carrying correct copies of the gene whose mutation 
causes the disease. This approach obviously requires the implicated genes to 
be identified and therefore the availability of efficient genotyping methods. 
Gene replacement therapy is relatively simple for RP due to loss-of-function 
mutations (usually recessively inherited). In this case, it is predicted that the 
expression of wild-type cDNA in the appropriate cell (photoreceptor or RPE) 
will avoid cell death. The most advanced experimental studies in this 
direction have been performed in blind dogs mimicking Leber’s congenital 
amaurosis (LCA).  The group of J. Bennett succeeded in surgical 
administration in the subretinal space of AAV vectors carrying the RPE65 
cDNA, allowing restoration of vision in four month-old dogs in USA (Acland 
et al. 2001). Five years later, the dog vision was still stable, and at present the 
long-term efficiency of the cure seems ascertained.  
 Several clinical trials are currently ongoing in RPE65 patients, and 
more than 30 patients have been treated to date. For example in the Jacobson 
Study, which employed an adeno-associated virus 2 carrying the RPE65 gene 
on 15 patients, no ocular adverse events or systemic toxicity were detected 
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related to surgery or to the viral vector itself. Visual function improved in all 
patients to different degrees and improvements were localized to treated 
retinal areas. Cone and rod sensitivities increased significantly in the treated 
eyes but not in the control eyes. Yet a group of patients with better foveal 
structure lost retinal thickness and acuity after sub-foveal injections. Even 
though only a very limited number of patients will greatly benefit from this 
still experimental treatment protocol, the technique itself has been shown to 
be safe and will likely be used in other retinal disorders in the near future. At 
date a canine model for achromatopsia has been treated successfully as well 
as mouse models for different forms of LCA.  
 Gene therapy is more complicated for RP due to dominant negative 
pathogenic mechanisms in which the expression of the mutated gene should 
be both inhibited and replaced. Experimentally, inhibition has been achieved 
by use of ribozymes or siRNA. In the last 10 years, studies have been carried 
out in several animal models with gain-of-function mutations. Although all 
studies showed a significant rescue of photoreceptors upon gene therapy, 
there was still progressing photoreceptor death, which could be due to an 
inappropriate expression level of the therapeutic gene and to an insufficient 
percentage of transduced photoreceptors. Thus, for patients with autosomal 
dominant Retinitis pigmentosa (adRP), a combined gene knockdown and 
gene addition therapy is being developed using RNA interference to block 
mRNA of the mutant allele (Stieger and Lorenz 2010). 
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 3.4.6 Optogenetic approach 
 
Based on the assumption that photoreceptors work differently than most 
neurons, since they hyperpolarize when stimulated, Busskamp et al. used an 
adeno-associated vector (AAV) to deliver halorhodopsin, a light-activated 
chloride pump of archaebacteria (Nagel et al. 2003), to cone photoreceptors in 
two mouse models of RP. The aim of this approach was to bypass the need 
for the normal light sensor (opsin) in cones and the normal phototransduction 
process. The authors detected light-induced electrical currents in the vector-
infected photoreceptor cells, not unlike those measured in normal cones, in 
which light stimulates cone opsin (Sieving et al. 2006). For those patients 
suffering from RP with unknown mutations, an AAV-based transfer of 
bacterial forms of rhodopsin in the central retina might be an option to 
reactivate residual photoreceptors in the future. In perspective, cones should 
be treated with a dual gene therapy, a viral vector that delivers a gene to 
combat the underlying cause of death, along with the halorhodopsin gene. 
Alternatively, a combination therapy of antioxidants, and/or growth factors, 
and AAV-halorodopsin might prolong cone survival and function. 
 
3.4.7 Cell or tissue transplantation 
 
The first successful transplant of a mammalian retina happened in 1959, when 
Royo and Quay transplanted fetal rat retinas into the eyes of adults of the 
same strain (Royo and Quay 1959). Although the transplanted retinas did not 
seem to connect with the host retinas, they survived for months. Since then, 
photoreceptor replacement has been shown to be feasible in RP animal 
models, but any cell-replacement strategy will require a source of new retinal 
cells. Retinal cells from fetal or adult retinas have been transplanted in 
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humans, and layers of photoreceptors or even entire retinas in animal models 
(rats and rabbits). Generally, the survival of transplanted photoreceptors is 
rarely observed; moreover, they do not organize in the retina (forming 
rosettes) and lack, with rare exceptions, functional synapses (Hamel 2006).  
 Researchers are also becoming interested in using embryonic or adult 
stem cells, since fetal or embryonic retinal progenitors can be grown in vitro 
(Anchan et al. 1991) and used for transplantation (Klassen et al. 2004). 
Neurospheres can be grown from the adult pigmented ciliary epithelium, and 
these cells can also be transplanted into the retina (Coles et al. 2006). Neural 
stem cells derived from the hippocampus show a good ability to integrate into 
the retinal layers and form morphologically normal-appearing retinal neurons 
(Suzuki et al. 2006).  
 The best evidence for functional photoreceptor replacement comes 
from the study of MacLaren et al. (2006), in which freshly dissociated, 
postmitotic rod photoreceptors were transplanted to the subretinal space; 
however, the limited number of implanted cells could not be expanded in 
vitro due to their postmitotic state. 
 Embryonic stem cells (ESCs) might be a good source for replacement 
of photoreceptors, but this therapeutic approach is still far from realistic use in 
a near future. In spite of the possibility that retinal transplantation might 
constitute a hope for the restoration of vision, getting the transplanted cells to 
establish right connections within the retina has remained a major problem by 
far. It appears that an early developmental stage of the retina of acceptor’s 
represents a key feature of a successful transplant. Despite decades of 
experimental attempts, transplants have yet to produce better vision in 
mammals with retinal degeneration because the transplanted cells do not wire 
up properly. 
 It has been proven that the RPE grafts may rescue the photoreceptors in 
Royal College of Surgeons (RCS) rats, in which a mutation of c.Merk causes 
a retinal dystrophy by lack of outer segment phagocytosis of the RPE. A 
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similar mutation causes a rare form of RP in humans (Li and Turner 1988). In 
RP due to RPE defects, RPE transplantation is then theoretically possible, but 
the immunogenic reaction against allogenic, wild type RPE is a limitation to 
this approach. 
 Based on a different rationale, promising results for RP treatment have 
been obtained by Otani et al. (2004), still using a cell-based approach. These 
authors have shown that injections of hematopoietic stem cells (lineage-
negative called Lin-HSCs) into the eye of mouse models of RP (rd1 and rd10 
mice) result into a dramatic rescue of both blood vessels and photoreceptors, 
mainly cones. These mice show an improvement of the ERG at an age when 
usually it is completely extinct and the rescue effects are long lasting. 
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3.4.8 Neurotrophic factors 
 
In humans, it would be sufficient to preserve 10% of all cones to maintain an 
independent life, while 50% of cone functionality would ensure a normal 
vision acuity (Hartong et al. 2006). Thus, neuroprotection appears as a 
promising and feasible approach. In addition, neuroprotection would work 
independently of the underlying genetic mutation causing RP, and therefore 
could bypass the tremendous genetic heterogeneity of this disease and the 
high incidence of sporadic cases.  
 Various studies tested different neurotrophic factors for their ability to 
slow retinal cell loss (LaVail et al. 1998). Some of them have been found to 
be effective when injected into the vitreous or in the subretinal space (Chong 
et al. 1999), or given as a supplement to transplants (Panni et al. 1994). It has 
been shown that four different neurotrophic factors, and namely ciliary 
neurotrophic factor (CNTF), basic fibroblast growth factor (bFGF), brain-
derived neurotrophic factor (BDNF) and nerve growth factor (NGF) and one 
‘viability’ factor (rod-derived cone viability factor) delay rod degeneration in 
some animal models of RP (Caffe et al. 2001). Among them, CNTF shows 
efficacy in 13 different animal models and has progressed to a phase II 
clinical trial in RP (Chaum 2003). Therefore, CNTF is currently considered 
the most effective neurotrophin to protect photoreceptors from degeneration 
(Sieving et al. 2006).  
 Exogenous administration methods for neurotrophic factor delivery to 
the retina have mostly relied upon intraocular injections (Whiteley et al. 
2001). More recently, a delivery system based on the endovitreal implant of a 
special capsule (Fig. 8.A) containing engineered cells (Fig. 8.B) has been 
devised by Tao and co-workers (2002). The encapsulated cells produce 
CTNF. The results of a recent phase I trial of an encapsulated cell therapy 
delivering CNTF are presently under evaluation (MacDonald et al. 2007). 
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Fig. 8. Schematic illustration of CNTF secreting implant using Encapsulated Cell 
Technology. The implant is composed of a section of semi-permeable membrane capsule 
which contains CNTF-secreting cells and scaffold. The membrane capsule is sealed at both 
ends with a suture clip at one end for anchoring on the sclera (A). The membrane allows 
O2 and nutrients to diffuse in and therapeutic agent (CNTF in this case) to diffuse out. It 
also keeps components of the immune system out (B). The implant is 6 mm in length and 1 
mm in diameter. It is outside the visual axis of the eye when anchored to the sclera 
(C).From R. Wen et al.2012. 
 
 A very important discovery is the existence of intraretinal viability 
factors. It is postulated that these molecules are normally released by rods 
(among other cells) and sustain the survival of cones. The latter would 
undergo secondary degeneration when the density of rods (and therefore the 
supply of factor) falls below a certain threshold. The French laboratory of 
Sahel and collaborators has been the first to isolate what has been called the 
rod-derived cone-viability factor (RdCVf) (Leveillard et al. 2004). These 
authors observed that in retinal cultures from chicken embryos cones 
degenerated after a few days. However, the degeneration could be 
considerably delayed by supplementing the culture with medium derived from 
wild-type mouse retinal explants. This early experiment led to the 
biochemical characterization of RdCVF, a secreted protein expressed in rods 
and necessary for the survival of cones. The injection of antibodies anti 
RdCVF in the subretinal space of wt mice causes a remarkable reduction in 
cone number. The administration of RdCVF in rd1 mice preserves about 40% 
of cones from degeneration. At present, the French group is working on the 
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mechanism of action of this molecule, also devising pre-clinical trial studies 
for its application on humans.  
 
3.5 Enviromental Enrichment (EE) 
 
We know that the quality and intensity of environmental stimulation can 
influence both neural development and plasticity in the adult brain. This 
concept was first clearly articulated by Hebb in 1949 ( Hebb D.O., The 
organization of behavior; a neuropsychological theory. Wiley, New York, 
1949). Hebb proposed that synapses are strengthened when presynaptic fibers 
repeatedly participate in activating the postsynaptic neuron. Subsequently, 
Hubel and Wiesel’s classic experiments (Hubel and Wiesel 1970) 
demonstrated that the environment influences neural plasticity and 
neurodevelopment in the cat visual system. Rosensweig and colleagues in the 
1960’s (Rosenzweig et al. 1962; Rosenzweig 1966; Rosenzweig et al. 1969) 
systematically began to examine the influence of environmental enrichment 
on cognitive functions, brain weight, cortical thickness and the structure of 
dendrites. In these early studies, Environmental Enrichment was defined as a 
“combination of complex inanimate and social stimulation” (Rosenzweig et 
al. 1978). Obviously, this concept is relative: an environmental setting is 
enriched with respect to another conditions that may lack some stimuli. An 
essential component of a typical EE setting is the opportunity to perform high 
levels of voluntary physical activity on running wheels (Spolidoro et al. 
2009). Therefore, living in an enriched environment provides the animals with 
optimal conditions for enhanced exploration, cognitive activity, social 
interaction and physical exercise. 
It is know that EE is a way of rearing the animals in a setting more similar to 
the wildlife: a sort of naturalistic-like condition. However, the observation of 
rodents playing in an Enriched Environment, choosing when and how much 
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to run on the wheel and to explore the new objects show that EE is not only a 
way to reproduce more natural life conditions. Rather, EE implies a kind of 
challenge-free interaction with a stimulating surrounding, with few stressful 
experience then normal. We can also argue that, although the activity of mice 
in the wild is mostly driven by necessity, and can introduce some stressful 
experiences, in an EE it is usually prompted by a combination of curiosity and 
play, because it is carried on with pleasure. 
 
3.5.1 Effects of EE on visual system development 
 
In spite of the vast literature on the effects of EE on the CNS, it was only 
during the past decade that new light has been shed on the remarkable EE 
impact on the developmental plasticity of the visual system. 
 The most remarkable effect that an EE procedure started from birth 
produces on visual system development is an accelerated maturation of the 
visual system acuity (VA). This has been initially studied in mice both 
electrophysiologically, by visual-evoked potentials (VEPs) recordings, and 
behaviorally, by visual water box task, a visual discrimination task (Cancedda 
et al. 2004). EE influences also the possibility to induce long-term 
potentiation (LTP) of layer II-III field potentials after theta-burst stimulation 
of the white matter (WM/II-III LTP) in the visual cortex, a well established in 
vitro model of developmental plasticity not present in the adult cortex (Huang 
et al. 1999). The processes underlying cortical plasticity induced by EE are 
not well known but different studies agree that there are several molecules 
involved. One of the most important appears to be BDNF. Indeed, in mice 
reared from birth in enriched conditions the expression of this neurotrophic 
factor is significantly higher in their visual cortex at P7 with respect to mice 
of the same age reared under standard conditions. It is also important to know 
that such an increase does not persist after P10 (SC) (Sale et al. 2004). Huang 
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and colleagues in 1999 found, in transgenic animals over-expressing BDNF, 
that this molecule accelerates the development of the inhibitory GABAergic 
system. This affects the receptive field development and cortex synaptic 
plasticity, determining a faster maturation of VA and the accelerated decline 
of synaptic plasticity. This model is also confirmed in EE mice, in which an 
increased expression of the GABA biosynthetic enzymes GAD65 and GAD67 
has been found in enriched pups at both P7 and P15 (Cancedda et al. 2004; 
Sale et al. 2004). 
 Another molecule that seems to be crucial for the effects elicited by EE 
at visual cortical level is IGF-I and his co-factor mTOR. IGF-I increases 
postnatally in the visual cortex of enriched rats and post-weaning 
administration of this molecule in the same structure mimics the EE effects on 
VA acceleration (Ciucci et al. 2007). Blocking IGF-I action in the visual 
cortex of developing enriched animals, completely prevents the EE effects on 
VA acceleration (Ciucci et al. 2007).  
 One of the targets of IGF-I and BDNF signaling is the activation of the 
transcription factor CREB. Indeed, it has been demonstrated by Cancedda et 
al. (2004) that animals enriched from birth display an accelerated time course 
of CRE/CREB induced gene expression and that treatment of non-EE mice 
with rolipram, (a specific inhibitor of the high affinity phosphodiesterase type 
IV that, in turn, activates cAMP system resulting in an increased 
phosphorilation of the transcription factor CREB), partially mimics EE effects 
on CREB pathway and on visual acuity development. Moreover, it is very 
likely that EE effects are not restricted to the visual cortex only, as suggested 
by the influence on CRE-mediated gene expression observed in the 
somatosensory cortex as well (Cancedda et al. 2004) . 
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3.5.2 Maternal enrichment and visual-system development 
 
Experiences acquired between birth and weaning age are essential in 
promoting and regulating neural development and behavioral traits in the 
newborn of most mammalian species (Fleming et al. 1999). A key point of 
this assumption is that newborn animals reared in EE do not interact with the 
external environment for, at least, the first two weeks of life, spending most of 
their time in the nest, totally dependent on the mother and, in the case of 
mammalians that live in large social groups, on the mother helper, which are 
the most important source of sensory experience for the developing pups (Liu 
et al. 2000). The thesis that maternal behavior could be the most important 
source of environmental stimuli for the accelerated development of enriched 
pups has been directly confirmed by a detailed quantitative analysis of 
maternal care, which turned out to be higher in pups reared under enriched 
conditions compared to standard reared pups (Sale et al. 2004).  
 The enhanced tactile stimulation and the continuous physical contact 
that enriched pups receive from their mothers seem to greatly influence brain 
development, providing a source for the earliest changes observed under 
enriched conditions. All these results are in line with the findings that the 
offspring of mothers that express higher levels of pup licking and grooming 
and arched back nursing, show increased expression of NMDA receptor 
subunit and BDNF-mRNA, increased cholinergic innervation of the 
hippocampus and enhanced spatial learning and memory (Liu et al. 2000). 
Moreover, Meaney and co-workers (2001) (Meaney 2001; Meaney 2001) 
found that naturally occurring variations in maternal care alter the expression 
of genes that regulate behavioral and endocrine response to stress, as well as 
hippocampal synaptic development. These effects form the basis for the 
development of stable, individual differences in stress reactivity and certain 
forms of cognition. Strikingly, part of these different abilities to respond to 
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stress in individuals are due to epigenetic mechanisms occurring at the level 
of chromatin structure and function: higher demethylation occurs in the 
hippocampus of the offspring that receive more maternal cares, at the level of 
the glucocorticoid receptor (GR) gene promoter (Weaver et al. 2004), 
facilitating transcription and leading to higher hippocampal density of 
glucocorticoid receptor . 
 More recently, an essential role for maternal stimulation in driving the 
development of the visual system has been provided by the work of Guzzetta 
and colleagues (2009), who hypothesized that enriching the environment in 
terms of body massage accelerates brain development in infants. The results 
from this work indicate that enriching the environment in terms of 
multisensory stimulation “massage therapy” affects brain development and in 
particular visual system maturation in both human preterm babies and rat 
pups. This not only underlines the importance of the environment as a driving 
force in early postnatal development, but also suggests that the environment 
acts modulating the level of endogenous factors such as IGF-1(Landi et al. 
2007; Landi et al. 2009).  
 
3.5.3 EE influences retinal development 
 
Most studies have investigated the numerous beneficial effects of EE on brain 
and behavior. Recently, the issue has been raised whether EE can also affect 
structures traditionally considered less plastic then the visual cortex, such as 
the retina. It is generally assumed that retinal development is independent 
from sensory and epigenetic inputs and that retinal acuity is not conditioned 
by visual deprivation, such as monocular deprivation (MD) or dark rearing 
(DR), which, on the contrary, have dramatic effects on visual-cortical acuity 
(Fagiolini et al. 1994; Fine et al. 2003). This traditional view has been 
challenged; indeed, it has been shown that dark rearing impairs retinal 
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development in mice, preventing the segregation of the ON and OFF 
pathways both at the electrophysiological and anatomical level (Tian and 
Copenhagen 2003). Moreover, Landi and colleagues in a 2007 study have 
shown that EE dramatically influences retinal development. By performing 
pattern electroretinogram (a sensitive measure of retinal ganglion cells 
function) recordings from enriched and standard reared rats, they found that 
retinal acuity development is sensitive to EE on the same time scale as 
cortical acuity. These authors also reported a significant acceleration of RGC 
dendritic segregation into ON and OFF retinal sublaminae in enriched 
animals. They also tested if and how BDNF is involved in these processes: 
when the neurotrophin expression was blocked in the retina of enriched pups, 
all the effects elicited by EE were completely prevented (Landi et al. 2007). 
 Strikingly, EE turned out to very effective also during fetal 
development. In a recent work by Sale and colleagues (Sale et al. 2007), it has 
been shown that in the embryos of pregnant rats housed in an enriched 
environment there was a marked acceleration in the development of retinal 
morphology, with faster dynamics of neural progenitor migration and natural 
cell death. Interestingly, all these effects found in enriched fetuses were under 
the control of IGF-I, whose levels were higher not only in the milk of 
pregnant rats, but also in the retina of the embryos. Silencing of this molecule 
in enriched mothers completely prevented the accelerating EE effects. 
Furthermore, the infusion of IGF-I in standard pregnant mothers mimicked 
the positive effects of EE found in enriched fetuses (Sale et al., 2007). 
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3.5.4 EE and pathology 
 
It has been demonstrated by several studies (for a complete review see 
also Baroncelli et al. 2011) that exposure to an EE elicits positive effects on 
recovery from pathological conditions, stress and aging. Since 1956 Bilowit 
et al. (1956) provided evidence that sensory-motor stimulation played an 
important role in ameliorating Parkinson's disease symptoms.  
More recent studies have reported also an effect of EE on increased 
hippocampal neurogenesis (Kempermann et al. 1997) and on the reduction of 
apoptotic cell death (Williamson et al. 2012). 
Moreover rearing animal models (transgenic animals) of nervous system 
disorders, including neuorodegenerative diseases (for a complete review see 
also (Nithianantharajah and Hannan 2006) and brain injuries (Johansson 
1996, Comeau et al 2008), in an enriched environment, leads to striking 
beneficial effects. 
Recently, several studies on the mechanisms that limit plasticity to early 
life, indicate that the brain is not “hard-wired” whit fix and immutable neural 
circuits, but that genes and environment work in concert in shaping CNS 
connections and behavior, even in hereditary pathological conditions (for 
review see Rutter 2007). 
In this Thesis we consider an inherited disease, Retinitis pigmentosa 
(RP), which affects neurons (photoreceptors in first place) in an area of the 
CNS shown to be sensitive to EE; survival of these neurons is prolonged by 
various neurothropic factors and cytokines and some of them (like BDNF) are 
increased in rodent paradigms of EE. For these reasons it is well-grounded to 
hypothesize EE as a strategy to delay RP symptoms in the mouse model 
employed here and, in perspective, in human patients. The Results obtained 
collectively support this view. 
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4 MATERIALS AND METHODS 
 
4.1 Animals 
 
All the experimental procedures were in accordance with Italian and 
International institutional guidelines. Mice of the rd10 strain (on a C57Bl6/J 
background) and wild-type (wt) C57Bl6/J mice (both from the Jackson 
Laboratories, Bar Harbor, ME) were kept in a local facility with water and 
food ad libitum, in a 12-hour light/dark cycle, with illumination levels below 
60 lux.  
 
4.2 Rearing environments 
 
4.2.1 Standard environment 
 
Control animals were rd10 mice born and raised in the same room, with the 
same illumination levels and administered the same diet of enriched mice. 
Control cages were standard laboratory cages of smaller size (42x26x 18 cm), 
without objects and hosting only the pregnant female and, later, her litter. The 
litter remained in the same cage until retinal examination, performed at the 
same age of EE mice. 
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4.2.2 Enriched Environment 
 
Enriched environment consisted of a large size (60x38x20 cm) Plexiglass 
cage containing a running wheel, at least two Plexiglass tunnels, hard-pressed 
cardboard nesting material, and 6-8 small objects which were replaced once a 
week. An rd10 female was placed in an enrichment cage with a male. Five 
additional and older females, previously mothers (helpers), were also present. 
The rd10 progeny (usually, 6-8 pups) remained in the same enriched 
environment up to the time of final testing and retinal examination (performed 
at 24, 45, 60 and 360 days).  
 
 
 
 
 
 
 
 
 
 
 
Fig. 9. Environmental Enrichment (EE) is a manipulation of the standard laboratory 
conditions that modify the quality and intensity of environmental stimulation, reaching an 
optimization of the rearing environment. The goal of EE is to provide animals with 
increased levels of multisensory stimulation, physical activity and social interactions, and 
by eliciting spontaneous explorative behaviors. 
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4.3 Fluorescence microscopy for pycnotic photoreceptors 
 
Mice from EE and ST at P24 were deeply anaesthetized intraperitoneally with 
Avertine (tribromoethanol in amylene hydrate 20µl/gm of body weight). For 
retinal histology, after eye enucleation, mice were euthanized with an 
overdose of the same agent. Eyes were quickly enucleated making a reference 
on the dorsal pole with permanent ink, rinsed and then eye cups were fixed in 
4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB, pH 7.4), for 1 
hour. Afterwards they were included in 30% sucrose in 0.1 M PB o/n and 
frozen in tissue-tek (Sakura, NL) at -20 °C . The retinas were detached and 
whole mounts pre-treated with RNAase A (1:500;Invitrogen) at 37°C in a 
solution with 0,5% Triton X-100 for 1 hour, washed extensively and then 
stained for 1 hr with Ethidium homodimer 2 Invitrogen. This is a fluorescent 
DNA-intercalating molecule to which fixed tissue is permeable, but that also 
stains RNA. Whole-mounted retinas were examined under a Leica TCS-SP 
confocal microscope for the presence of pycnotic (apoptotic) photoreceptor 
nuclei, brighter than others for their condensed DNA. The ONL, containing 
the nuclei of photoreceptors, was sampled along the whole z axis. 
Photoreceptor pycnotic nuclei were counted on projection images of the ONL 
in fields of 150.6 × 150.6 μm2 (32 fields/retina), spaced at 500-μm intervals 
along the dorsal-ventral and nasal-temporal retinal meridians. The total 
number of pycnotic photoreceptors for each retina was calculated by 
multiplying the average density of pycnotic cells in field images by the 
corresponding retinal area, measured by low-power light microscopy with an 
image analyzer.  
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4.4 Immunofluorescence: cone counting 
 
Mice were deeply anaesthetized as described previously. For retinal histology, 
after eye enucleation, mice were euthanized with an overdose of the same 
agent (Avertine; 20µl/gm of body weight). Eyes were quickly enucleated 
making a reference on the dorsal pole with permanent ink, rinsed and then eye 
cups were fixed in 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer 
(PB, pH 7.4), for 1 hour. Afterwards they were included in 30% sucrose in 0.1 
M PB o/n and frozen in tissue-tek (Sakura, NL) at -20 °C. For whole mount 
staining, the eye cup were de-frosted, the retinas isolated, deprived of 
pigmented epithelium, and 4 incisures were cut to identify the main 
quadrants. The retinas were then washed in 0.1 M PB (3x 10 minutes) and left 
over night in a blocking solution with 0,5% Triton X-100, 5% BSA in 
phosphate-buffered saline (PBS; pH 7.4) at 4°C. The day after, the retinas 
were placed in a solution of rabbit anti-Red/Green Opsin and anti-Bue Opsin 
antibodies (3 days at 4°C, 1:500; SIGMA) revealed with Alexa-568 secondary 
antibodies (2 hours at RT. 1:1000; Invitrogen). All solutions contained 0,3% 
Triton X-100, 0,5% BSA in phosphate-buffered saline (PBS; pH 7.4). 
 To estimate the number of cones in EE, ST and wt mice at p45 and p60, 
we used 6 retinas (from 6 different mice) from both EE and ST mice and 2 
retinas from wt mice. Each retina was systematically imaged with a Peltier-
cooled Axiocam color camera interfaced with a Zeiss Axioscope fluorescence 
microscope, using a 5x objective. Images were assembled into single, high 
resolution montages of the whole retinal surface by means of Adobe 
PhotoMerge. Using differences in labeling brightness, displayed on the 
images as color gradients, cone isodensity curves were then traced digitally. 
Cone densities within each curve were estimated separately by counting cones 
on high resolution confocal images. For this purpose, serial optical sections 
were obtained at 0.5 µm intervals to cover the thickness of the entire layer 
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containing the outer segments. Scanning areas were 16 fields 375X375 sq. 
micrometers. Fields were regularly spaced along the dorso-ventral and naso-
temporal retinal meridians. Counts of cone outer segments were performed on 
serial reconstructions covering the entire thickness of the outer segments by 
stacking a series of single focal planes (usually 3 -4 consecutive planes, each 
of them 0.5 µm thick), with the aid of Metamorph® software. 
 Locally estimated cone densities were assigned to the corresponding 
areas displayed on a retinal map. Total numbers of cells were obtained 
multiplying average cellular densities by corresponding retinal areas. 
Statistical analysis (t-test) was performed with OriginPro 7.0. Average density 
values at each retinal locations were used to generate 7x7 squared matrices 
that were then analyzed with Sigmaplot 8.0 software, to obtain retinal 
isodensity maps with a dedicated SigmaPlot application. 
 
4.5 Fluorescence microscopy on retinal vertical sections 
 
Retinas from three animals of rd10 EE, ST and wt mice at P45, P60 and P360 
were harvested for morphological analysis. Photoreceptor survival was 
assessed by counting nuclei in the ONL. Photoreceptor morphology was 
assessed by immunohistochemistry. 
 Eyes were removed, fixed for 1 h in 4% paraformaldehyde in 0.1 M 
sodium PB buffer (pH 7.4), infiltrated with 30% sucrose in the same buffer, 
and frozen at −20 °C on a cryostat stage (Leica). Vertical sections of 14 μm 
were cut, collected on glass microscope slides. For the stain with Ethidium 
homodimer 2 (1:1000, Invitrogen) or YOYO (1:1000, Invitrogen) slice were 
treated with RNAase A (1:500) at 37°C in a solution with 0,5% Triton X-100 
prior to examination by confocal microscopy. We estimated the number of 
surviving photoreceptors by counting the rows of nuclei in the outer nuclear 
layer on high-resolution images of vertical sections obtained from both central 
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and peripheral retinal areas (10 images/retina, each covering a linear retinal 
extension of 250 μm). Mean values per retina were averaged per group and 
expressed as mean and SE. At least 3 retinas/age group were examined. 
 For immunocytochemistry of photoreceptor morphology and retinal 
histology, retinal sections were treated as follows: Primary antibodies used 
were are reported in Table 1. Before the incubation with the primary 
antibodies, retinal sections were incubated with a blocking solution containing 
0.5% Triton X-100, 5% BSA , PBS; pH 7.4, at RT for 2 hours. The antibodies 
were diluted in the same buffer with 0.1% Triton X-100, 0.5% BSA and 
revealed with anti-mouse Oregon Green 488,anti-mouse Alexa Fluor 488; and 
anti-rabbit Alexa 568 (all used as 1:400); or anti-mouse/anti-rabbit rodamine 
RedX-conjugated (1:500, Jackson Immunoresearch laboratories) secondary 
antibodies. Retinal sections were counterstained with Ethidium homodimer 2 
or with YOYO to reveal nuclei. 
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Table 1: Primary antibodies used in indirect fluorescence 
immunocytochemistry 
 
 
Primary 
Antibody 
Working 
dilution 
Host;  
source Main target 
Rhodopsin 1:1000 Mouse monoclonal;  SIGMA rods 
S Opsin 1:500 Rabbit policlonal; CHEMICON S-cones 
M/L Opsin 1:500 Rabbit policlonal; CHEMICON M/L cones 
PSD-95 1:500 Mouse monoclonal; CHEMICON 
Photoreceptor 
synaptic terminals  
Protein 
Kinase C 
(PKC) 
1:1000 Rabbit policlonal;  SIGMA Rod bipolar cells 
Protein 
Kinase C 
(PKC) clone 
MC5 
1:1000 Mouse monoclonal;  SIGMA Rod bipolar cells 
Calbindin D 
28K 1:500 
Mouse monoclonal;  
SIGMA 
Horizontal and 
amacrine cells 
Bassoon 1:500 Mouse monoclonal;  SIGMA 
Photoreceptor 
synapses 
cGMP-gated, 
rod specific 
channel 
1:500 
Mouse monoclonal; a kind 
gift of Prof. Joseph Beavo 
University of Washington 
Dep.of Pharmacology 
Outer segments of 
rods 
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4.6 Western blot 
 
To detect photoreceptor-specific proteins in retinal tissues of different 
experimental groups, we performed Western blot on corresponding retinal 
homogenates. 
 Three EE and ST mice aged P45 and P60 were anesthetized as 
described earlier, eyes removed rapidly, retinas detached and frozen on dry 
ice. Two retinas for each mouse were then homogenized in a lysis buffer 
containing (in mM): Tris (pH 7.4), 50; EDTA, 1; sodium pyrophosphate, 1; 
NaCl, 150 ;sodium orthovanadate, 1; NP40, 1%, Na-deoxicolate, 0,25% and 
phenylmethylsulfonylfluoride, 1; with aprotinin, 10 mg/mL; leupeptin 
(Sigma, Italy), 10 mg/mL. Samples were first homogenated and subjected to 
lysis for 30 minutes at 4°C, after the insoluble fraction was pelleted by 
centrifugation (12,000 rpm; 30 min; 4°C). The protein pellet was then 
recuperated and the protein concentration determined by Biorad assay 
(Biorad, Italy). Subsequently, 60 mg homogenate from each sample, for each 
line in duplicate, was loaded into 12% acrylamide gels using the Precast Gel 
System (Biorad, Italy). Samples were blotted onto PVDF membrane (Bio-Rad 
Laboratories), blocked in 10% nonfat dry milk in Tris buffered saline with 1% 
NP40 for 1 hr, and then probed with Monoclonal anti Rhodopsin (1:1000 
Chemicon), Monoclonal anti β Actin Clone AC-74 (1:20.000 SIGMA), 
Monoclonal anti CGMP gated cannel (1:1000), Polyconal anti OPN1MW/LW 
(H-55) (1:1000 Santa Cruz biotechnology), Polyclonal anti Blue sensitive 
opsin (H-40) (1:1000 Santa Cruz biotechnology). All antibodies were diluted 
in NP-40 1% Tris Buffered Saline (TBS) and 5% milk incubated overnight at 
4°C. Blots were then rinsed for 20 min in TBS NP-40, incubated in 
horseradish peroxidase-conjugated anti-mouse or anti-rabbit (1:3000; Biorad, 
Italy, in 5% milk and TBS NP-40), rinsed, incubated in enhanced 
chemiluminescent substrate (Biorad), and exposed to film (Hyperfilm; 
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Amersham Biosciences, Europe). Films were scanned, and densitometry was 
analyzed through ImageJ free software (http://rsb.info.nih.gov/ij/). 
 To minimize variability, each sample was loaded in parallel in two 
lanes and two gels were run simultaneously on the same apparatus. The 
densitometric quantification of the band corresponding to Rhodopsin, Cone 
specific Opsin and Ligth-sensitive channel was then normalized to the value 
obtained for the total amount of Actin from the same gel. Results are 
presented as a significative example of multiple experiments. 
 
4.7 qPCR 
 
The reverse transcription polymerase chain reaction (RT-PCR) is the most 
sensitive method for the detection of low-abundance mRNA, often obtained 
from limited tissue samples. The recent introduction of fluorescence-based 
kinetic RT-PCR procedures significantly simplifies the process of producing 
reproducible quantification of mRNAs and promises to overcome these 
limitations. The figure below shows a schematic procedure of both 
conventional RT-PCR and qPCR. 
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Fig. 10. Conventional RT-PCR. The reaction can be carried out either with reverse 
transcriptase in a separate reaction, followed by transfer of some of the cDNA into a 
second reaction for the PCR, or as a combined one-tube reaction with a heat-stable DNA-
dependent polymerase. The former may be more sensitive and has the advantage of 
generating a cDNA reservoir that can be re-used repeatedly to carry out further PCR 
reactions. The latter has the advantages of speed, simplicity and less chance of 
contamination. Maximum sensitivity is achieved using a nested PCR reaction; however, 
this is frequently at the cost of reduced specificity. Gel electrophoresis is common to all 
procedures, but Southern blotting and/or DNA sequencing may be required to confirm the 
identity of the amplicon. A final step involves some method for quantitating the bands on 
the gel. All subsequent steps are carried out by the thermal cycler/detector and a 
quantitative result is processed by computer. From: (Bustin 2000). 
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4.7.1 Template preparation  
 
In the procedure we followed, retinas are isolated from mice anesthetized as 
above and the lysis and homogenization of frozen retinas performed 
according to the QIAzol protocol (QIAGEN). 
 
4.7.2 Determining concentration and purity of nucleic acids 
 
The concentration of RNA is determined by measuring the absorbance at 260 
nm (A260) and at 280 nm (A280) in a spectrophotometer. The ratio between the 
absorbance values at 260 nm and 280 nm gives an estimate of the purity of 
RNA. For accuracy we perform a Acrylamide (1%) with formamide gel with 
1 µg of RNA before and after the Reverse transcription reaction.  
Purified RNA is stored at -20°C in RNase-free water. If the template is not 
degraded the experiment can be continued over time. 
 
4.7.3 Removal of genomic DNA contamination and cDNA synthesis 
 
For cDNA syntesis with integrated removal of genomic DNA contamination 
we use the QuantiTect Reverse Transcription Kit (QIAGEN) that is specific 
for Real time uses. For the retrotrascription reaction we use 0,5 µg of RNA. 
 
4.7.4 qPCR 
 
Quantitative real time PCR (qPCR) was performed using the TaqMan® Gene 
Expression Assays (20x). We used 10 μL of PCR reaction mix into each well 
of a 48 well reaction plate (Applied Biosystem).  
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 The reference genes we use is glyceraldehyde-3-phosphate-
dehydrogenase (GADPH):Mm99999915_g1*. 
 For CNTF mRNA amplification we use the Inventoried assay: 
Mn00446373_m1. 
 We observed that this assay does not amplify genomic DNA. After the 
reaction, we run Amplicons on Agarose gel (1%) to control the effective 
presence of one Amplicon only, or weather annealing between the two 
primers had caused the undesired formation of multiple Amplicons. 
Initially, we used the Inventoried assay Mm01334043_m1 for BDNF mRNA 
amplification; since this assay detects also the Genomic DNA, we made a 
custom intron-spanning assay with the target sequence: 
Fw: GTTCCTTCAACTGCCACCACT 
Rw:GCCTTCATGCAACCGAAGTATGA 
Estimed Amplicon Size: 108 
In silico analysis gives an accuracy of 98% for this assay. 
 
4.7.5 Detection of a correct amplicon on gel 
 
To evaluate the correct procedure of amplification, the results of this step 
were loaded on a 1% Agarose gel. This method allows the direct 
observation of the amplicons used for the PCR and detects abnormal 
signaling (presence of Genomic DNA, incorrect annealing).  
 
4.7.6 Data analysis 
 
To perform calculations of real-time PCR results we used the Delta-Delta 
Ct method. Before that, we tested the efficiencies of all our primers, and 
found they have a similar efficiency. This means that the delta Ct remains 
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constant when we performed a series of 10-fold dilutions. This allows the 
use of the 2 
delta-delta Ct
 to calculate the difference in the expression of our 
genes in our samples. 
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4.8 Behavioral test: visual acuity and contrast sensitivity  
 
 Visual acuity is defined as the ability to detect small distance separating two 
points, and the threshold for visual acuity is reached when the observer can no 
longer determine a separation between two different points. Spatial frequency 
is a measure of how often sinusoidal components (as determined by the 
Fourier transform) of the structure repeat per unit of distance and is measured 
in cycles per degree (c/deg). For a grating stimulus, spatial frequency refers to 
the frequency with which the grating repeats per degree of visual angle. To 
determine the visual acuity in experimental mice we used the visual water box 
adapted by Prusky (Prusky et al. 2000). We used the same visual water box 
also for determining the contrast sensitivity. Contrast sensitivity is defined as 
the ability to perceive differences between an object and its background.  
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In both cases we trained P30 mice both from EE and from ST conditions to 
discriminate between vertical gratings whit different frequencies. Normally, 
mice with non-impaired vision were capable of pattern discrimination and 
they reached the criterion of 70% correct within the 8 days of testing. The 
rationale of the task described here is to use an animal’s ability to associate a 
grating with escape from water, as an index of its acuity. 
 The basic apparatus consists of a trapezoidal-shaped pool with two 
computer-controlled monitors placed side-by-side at one end (Fig. 11). A flat 
divider is painted black on both sides to make it opaque and reduce reflections 
within the pool. The length of the divider sets the choice point and effective 
spatial frequency: it is the closest an animal can get to the monitors without 
entering one of the two arms. A portable escape platform is placed below one 
of the monitors. The pool is filled with tepid (22°C) water. Screen reflections 
on the surface of the water render the platform invisible from water level. 
Visual stimuli are displayed on two identical computer monitors that face into 
the wide end of the pool. The bottoms of the screens are at water level. The 
black levels and contrast of the monitors are equated and the mean luminance 
is set at 39.95 candels/m2. The monitors are driven by a home-made software 
which presents visual stimuli in a left-right pseudo random order.  
 There are three phases in the task: 1) shaping; 2) task training and 3) 
acuity testing. In a shaping phase, animals are shaped gradually to locate a 
platform hidden below a screen displaying a low spatial frequency grating 
(0.117 cycles per degree). On the first trial, animals are removed from their 
holding cage and released, facing the screen, into the pool a few centimeters 
from the platform. On the next trial, the location of the grating and the 
platform are switched to the opposite side and another trial is run. After this 
routine is repeated a few times, the release distance from the platform is 
gradually increased until animals can reliably swim to the platform from the 
opposite end of the pool. In the training phase, animals are conditioned to 
distinguish between a low spatial frequency sine-wave grating (0.117 cpd) 
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and homogeneous gray. On all trials, animals are required to swim until they 
find the platform. After the animals have achieved near-perfect (80%) 
performance over 20–40 trials on a pseudorandom schedule in the training 
phase, the testing of visual acuity can begin. For the testing phase we used a 
method to minimize the number of incorrect responses by the animals (Prusky 
et al. 2000).small incremental changes in the spatial frequency of the stimulus 
were made between successive blocks of trials until the ability of animals to 
distinguish a grating from gray reached the same of the chance. If the animal 
made a correct choice, the spatial frequency of the stimulus was increased by 
adding one cycle on the screen, and another trial was executed. This 
procedure continued for the low spatial frequencies until an error was made. 
After the number of trials covering approximately half of the animal’s 
postulated threshold was completed, the minimum number of trials was 
increased to three, and then again increased to four around three-quarters of 
the projected threshold. This method of consecutive testing utilizes about 15 
different spatial frequencies. 
 We tested mice in groups of five to six in a session of ten interleaved 
trials, with each session lasting 45–60 min and no more than three sessions 
were performed in a single day. A preliminary threshold was attained when 
mice fail to achieve 70% accuracy at a spatial frequency. In order to ensure 
the accuracy of this estimate, spatial frequencies around the threshold were re-
tested until a clear pattern of performance was generated.  
 A similar procedure was used to measure contrast sensitivity but, in this 
case, we used the spatial frequency as a fixed parameter and the stimulus 
contrast as the changing one.  
 The highest spatial frequency or contrast achieved were recorded as the 
acuity threshold or contrast threshold, respectively. The data around the 
estimate were averaged and a frequency-of-seeing curve or a contrast-of-
seeing curve was built. The time necessary to estimate thresholds with 
accuracy varies between 2 and 3 days. 
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4.9 Electroretinogram recordings (ERG) 
 
To gain insight into retinal function of EE mice and ST mice we collaborated 
with the group of Prof. Gargini at the University of Pisa, who performed 
Electroretinogram (ERG) recordings. Mice were dark-adapted overnight and 
the day after anesthetized with an i.p. injection of uretane 20% (0,1 ml/10 g 
body weight). Body temperature was maintained at 37 °C. Pupils were dilated 
by administration of tropicamide (1%) eye drops, and the cornea was kept 
moist with a methylcellulose solution. For ERG recordings, an electronic 
flash unit generated a light stimulus of 492 nm whose energy decayed with a τ 
of 1.7 ms. Full-field stimulation was achieved using a Ganzfeld sphere, and 
flash intensities were attenuated by neutral-density filters. Mice were 
subjected to 8 different flash intensities, each repeated five times, with an 
interstimulus interval that ranged from 30 s for dim light to 60 s for the 
brightest flashes. The flash luminance was measured at the corneal plane in 
photometric units (cd·s/m2) using a Minolta CS100 photometer with a 
scotopic filter. ERG signals were recorded using coiled gold corneal 
electrodes. Responses were differentially amplified, band-pass-filtered at 0.3–
500 Hz, digitized at 0.25- to 0.5 ms intervals, and stored on disk for 
processing. 
 Five ERG traces at each flash luminance were averaged before 
measurements of b-wave amplitudes. The amplitude of the b-wave was 
measured from the trough of the a-wave to the peak of the b-wave. Isolated 
cone components (photopic ERG) were obtained by superimposing test 
flashes on a background of saturating intensity for rods (30 cd·s/m2). 
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5 RESULTS 
 
5.1 Early EE retards the onset of rod and cone loss during weaning  
 
In rd10 mice, rod death starts around postnatal day 18 (P18), peaks at around 
P24 and is almost complete by P40. A rod-driven ERG is extinguished at 
around P30. Cone death proceeds at a slower rate and a cone-mediated ERG 
can be recorded only up to P55-P60 (Gargini et al. 2007). 
 
5.1.1  Photoreceptor survival in EE: pycnotic photoreceptors 
 
We started our studies by estimating the death rate of rod photoreceptors, by 
counting pycnotic nuclei (positive for Ethidium homodimer 2 marker) in 
whole mount retinal preparations from rd10 mice aged P24 and reared either 
in EE or in ST condition. This age was chosen because, as already mentioned, 
it is around the peak of rod death for this mutant. 
 As shown in Fig. 12 , we found a higher number of pycnotic nuclei in 
ST as compared to age-matched EE retinas. Total values were: ST, 17156,51 
(SE±1619; n=6) pycnotic photoreceptor nuclei per retina; EE, 28698,29 
(SE±4449,8; n=6). Thus, EE delays the death of rods related to the rd10 
mutation. 
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Fig. 12. Pycnotic profiles in the ONL are lower in EE retinas (B) than in age matched 
mutants exposed to standard conditions (ST) (A). Red signal: Ethidium homodimer 2. The 
graphic shows counts of pycnotic cell nuclei in retinas from ST (black bars) and EE (red 
bars) rd10 mice at 24 days of age (C). Counts are from 6 retinas from different animals for 
each column. Bars indicate SEM. Student t-test: *p= 0.036. 
 
5.1.2 Photoreceptor survival in EE: quantitative analysis and 
morphology 
 
Two groups of 6 mice aged P45 from either EE and ST conditions were 
enucleated and their retinas used for evaluate the persistence of surviving 
cells in the ONL.  
We found that the number of surviving photoreceptors is consistently higher 
in retinas of rd10 P45 mice born and raised in EE than in those of rd10 age-
matched controls maintained in ST conditions (Fig.13). The number of 
photoreceptor rows in EE retinas have a mean of 1,57 (SE±0,33) against a 
mean of 1,15 (SE±0,04).  
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Fig. 13. Vertical retinal sections from 45-day-old rd10 mice raised in ST (A) and EE (B). 
Nuclear counterstaining in red is used for counting nuclear rows. EE is associated with a 
greater number of nuclear rows in the ONL. Counts are from 3 retinas from both groups 
(C). The number of photoreceptor rows in EE retinas is greater (mean 1,57± 0,10) than in 
ST retinas(1,15± 0,04) Student t-test. **: p=0.002.  
 
 We also assessed the preservation of single photoreceptor types by 
means of vertical sections from P45 EE and ST retinas. This study revealed 
that rods in retinas of EE mice have elongated outer segments and still 
express the light sensitive channel (“the” GMP channel specific for rods). a 
protein virtually missing in ST retinal samples (Fig. 14). 
 PSD95 (postsynaptic density 95 protein) is a well described marker of 
photoreceptor synaptic terminals in the OPL (Koulen et al. 1998). We found 
that this marker is still clearly identifiable in the OPL of EE retinas and 
almost undetectable in ST controls (Fig. 14).  
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Fig. 14. Vertical retinal sections from 45-day-old rd10 mice raised respectively in 
environmental enrichment (EE) (B) or in standard conditions (ST) (A). EE is associated 
with a greater number of nuclear rows and preservation of rod outer segments. A and B: 
cGMP-gated light-sensitive channel staining of rods (green) and nuclear counterstaining 
(red). C and D: PSD-95 staining for synaptic terminals of photoreceptors in the OPL 
(green) show that in EE retinas these are much better preserved. 
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5.1.3 Photoreceptors survival in EE: cones 
 
We found a higher preservation of cones in EE versus ST retinas aged 45 
days. This is clearly visible by immunocitochemistry on retinas slides, as it is 
shown in Fig. 15, where the sections are immunostained with cone-Opsins 
specific antibodies.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 15. Vertical retinal sections from ST mice (A) and EE mice (B) aged P45. Red signal 
shows immunostaining for cone outer segments that are better preserved than in ST mice. 
Nuclei are counterstained in green. 
 
 As described in Methods, we developed an ad hoc procedure for cone 
counting that allows to see local cell distributions in whole mount retinas. We 
validated this method counting two retinas from adult Wild Type (WT) mice 
of the same genetic background (C57BL/6) and obtaining a result similar to 
what previously shown in literature (Fig. 16) (Jeon et al. 1998). With this 
method, we found that at 45 days of age approximately 100,000 cones persist 
in retinas of EE rd10 mice, instead of a mean of 83,000 cones in ST rd10 
mice. An area devoid of cones starts to become visible in the central part of 
ST retinas at this age (Fig. 16). 
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Fig. 16. Examples of whole mount retina immunostaining for specific cone-Opsins (red) 
from mice aged P45 raised in ST and EE condition (A and B). 
High-magnification confocal images of retinas stained for cone-Opsins from rd10 mice 
raised in ST or in EE (C and D). Focus is on outer segments. Note that residual cones in 
ST start to lose outer segments while the latter are still considerably long in EE.  
Counts of cones in retinas from rd10 mice (n=6 for condition) raised in ST (black bar) and 
EE (red bar) at 45 days of age and from wild type mice at P60 (gray bar) (E).  
Values are mean of means and SEM. Student’s t test. *p=0.018. 
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5.1.4 Inner retina in EE: morphology 
 
Considerable literature shows that photoreceptors death is followed by a 
process of secondary remodeling that takes place in the inner retina and that 
includes dendritic retraction in bipolar and horizontal cells, displacement of 
rod bipolar cell bodies in the outer retina and progressive synaptic atrophy of 
the Outer Plexiform Layer (Marc et al. 2003). These processes also affect 
rd10 mice (Gargini et al., 2007).  
 We extended our observations to the inner retina of rd10 mutant mice 
born and raised in EE or born and raised in ST. Immunocitochemistry studies 
of P45 retinal sections revealed that the EE inner retina is better preserved 
than the ST inner retina. Indeed, rod bipolar cells still maintain their laminar 
position and their dendritic tree, and are still connected to photoreceptors as 
shown in Fig. 17. 
 
 
 
 
 
 
 
 
 
Fig. 17. Vertical retinal sections showing inner retina morphology in P45 mutant mice 
raised in ST condition (A) and EE conditions (B). Green signal: PKC immunostaining for 
rod bipolar cell shows how better preservation of their morphology in EE retinas. Red 
signal shows immunostaining for bassoon (a typical presynaptic protein).  
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 The quantification method based on topography after opsin-
immunostaining on whole mount retinas was used also on animals aged P60. 
Using 6 animals from EE and ST groups, we confirmed that twice as many 
cones survive in the EE compared to the ST retinas at this age. Approximately 
95,000 cones (i.e. over 65% of the cone population of a normal mouse retina) 
persist in retinas of EE rd10 mice at this age. This is a remarkable observation 
considering that only 52,000 aberrant cones (36% of the total number) survive 
in retinas from age-matched ST control animals. Unlike what we observed in 
P45 retinas, most of the opsin immunoreactivity in cones from ST retinas is 
concentrated in cell bodies while outer segments are virtually undetectable 
(Fig. 18). Cones with semi-normal morphology and shorter outer segments 
are observed in EE but not in ST mice (Fig. 18). 
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Fig. 18. Examples of retinal whole mounts from standard (A) and enriched (B) rd10 mice 
stained with antibodies against cone-specific opsins (red labeling). An area devoid of cones 
is clearly evident in the central part of the retina shown in A (blue line); a central-to-
periphery pattern of degeneration is typical of rodent models of RP. High magnification 
confocal images of cones from WT (E), rd10 ST (C) and rd10 EE (D) retinas. Note that 
residual cones have lost outer segments in C, while they are still considerably long in D. F: 
counts of retinal cones in retinas from ST (black bars) and EE (red bars) rd10 mice at 60 
days of age. The number of cones in the retina of normal, wt mice of the C57Bl6/J strain is 
also shown (shaded column). Bars indicate SEM. Student T test. **: p<0.01. Counts are 
from 6 retinas from different animals for each column. 
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Morphological signs of retinal regressive events are significantly reduced in 
rd10 EE mice (Fig. 19), where rod bipolar cells, stained with PKCα 
antibodies, show intimate association between dendrites and photoreceptor 
endings stained whit PSD95 in the Outer Plexiform Layer. Moreover, bassoon 
antibodies, labeling synaptic ribbons in photoreceptor terminals, show that 
these are also more preserved in EE than in ST controls (Fig. 19). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 19. Morphology of inner retinal cells in mice raised in ST (A and C)and EE (B and 
D). A and B: Vertical retinal sections stained with antibodies against PKCα (green), 
labeling rod bipolar cells, and with antibodies against PSD95 (red) that, in the outer 
plexiform layer (OPL), label synaptic contacts established by photoreceptors. Age is P60. 
In EE, bipolar cells dendrites are decorated by bassoon-positive puncta (red, bottom panel) 
(D) that are less numerous in ST (C).  
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 5.1.5 Photoreceptor survival in EE: western blot. 
 
We evaluated, by Western Blot analysis, the expression of photoreceptor 
specific proteins to validate the higher survival and preservation of rods and 
cones in EE rd10 mice. In line with what previously found by means of 
immunostaining techniques, we observed that retinal levels of the same 
photoreceptor-specific proteins (and namely, Light sensitive channel, 
Rhodopsin and cone-Opsins) are higher in retinas of EE than in ST age 
matched mice (Fig. 20A). Measurements performed on sets of 3 gels from 
different retinal samples show average values of cone-Opsins that are 20 % 
higher in EE as compared to ST samples. Similarly, the light sensitive 
channel has an expression of 54% higher  than ST level, while rhodopsin is 
10% higher in EE retinal preparations (Fig. 20B).  
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Fig. 20. (A) Western blots for photoreceptor specific proteins from retinal preparations 
obtained from ST and EE rd10 mice aged 60 days. The rod specific, cGMP-gated channel 
is 54% more express in EE retinas than ST retinas, also rhodopsin have an 10% higher 
expression in  EE than in the ST samples, respectively. Cone-Opsins are 20% higher 
expressed in EE than in ST retinas. Homogenates were obtained from 3 different retinal 
preparations. Loading on gel and subsequent quantification were done in duplicate.(B) 
western blot densitometry results normalized against each ST actin level. Values represent 
the arbitrary mean value. 
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5.1.6 Retinal physiology in EE: electroretinogram recordings 
 
Morphological preservation of cones does not imply automatically their 
ability to function properly. Hence, we used mice (ST and EE) to test the 
photoreceptor ability to respond to light by electrophysiological recording of 
the ERG in different age groups (P45, P60 and P75). Results from ERG 
measurements are illustrated in Figure 21. Individual photopic ERG 
responses from P60 EE and age-matched ST rd10 mice are compared in A. 
The photopic b-wave amplitude as a function of the flash luminance in P60 
EE and age-matched ST mice is compared in B. The amplitude of the 
photopic b-wave at P45, P60 and P75 is reported in C respectively for ST and 
EE exposed mice. It is seen that EE exposure is associated to photopic (i.e. 
cone-driven) responses that at P60 and P75 are significantly larger than in ST 
mice. 
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Fig. 21. (A) b-wave amplitudes of photopic ERG responses at high luminance  
(192,600 Rh*/photoreceptor) are significantly more preserved in EE at P60 . 
(B) Photopic ERG responses recorded at P60 and as a function of the flash intensity.At 
high intensities, amplitudes are significantly greater in mice raised in EE. Schematic 
representation of b-wave at P45, P60 and P75 is reported in (C) respectively for ST and EE 
exposed mice. Bars indicate SEM. Student t-Test (*p<0.05). 
 
 
5.1.7 Visual system physiology in EE: behavioral tests 
 
In a group of 10 EE and ST mice we assessed overall visual performance by 
measuring visual acuity and contrast sensitivity in photopic conditions by 
means of the visual water maze task. For both measurements, mice learn to 
locate an escaping submerged platform whose position is indicated by a visual 
stimulus consisting of a grating of increasing spatial frequency or decreasing 
contrast (see Methods for further details). The highest spatial frequency 
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perceived defines the upper limit of the visual acuity which in turn is set by 
the cone density (Prusky et al. 2000). At all the age tested, EE mice 
performed significantly better than age-matched ST. Indeed, despite we have 
trained the two groups of animals ( ST and EE) together at the age of P30, 
since the first age that we have tested EE mice performed an higher value of 
VA respect to ST age-matched mice. Starting from P45 ( the first age 
analyzed) EE mice had amean of VA of 0,44 instead of a mean of 0,26 c/dg of 
age-matched ST mice, later the ST mice Visual Acuity decrease and remain 
constant on a mean value of 0,23 and the EE mice VA remain higher (EE VA 
mean=0,29 c/dg). Even at 8 months of age, a residual average acuity of 0.20 
cycles/degree was still measured in EE animals. ST mice turned out unable to 
perform the test by the age of 6 months (Fig. 22).  
 In the same cohorts of animals we also measured contrast sensitivity 
using as stimuli black and white gratings of fixed frequency (0.117 
cycles/degree) and progressively decreasing contrast.  
Contrast sensitivity is of paramount importance in assessing the performance 
of the visual system because it also reflects the integrity of the overall 
neuronal processing of visual signals (Histed et al. 2011). We tested contrast 
sensitivity in EE and ST mice aged P45, P60 and P90 (Fig. 23). Although 
higher than in normal wt mice (Fig. 22) at 45 days, a minimum 7% contrast is 
necessary for task discrimination in EE mice; this value rises to 9% at 60 days 
and to 16% at 90 days. In age-matched ST mice, minimum contrast values 
were several times higher, namely 25% and 35% at, respectively, 45 and 60 
days, while they reached 55% at 90 days. 
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Fig. 22. Visual acuity measured at various ages in ST and EE mice with Prusky water 
maze. 
Acuity is significantly higher in EE animals at all the ages tested. Bars indicate SEM. 
Student t test. *** p<0.001. Each column is the average response from a cohort of 10 
animals. 
 
 
 
 
 
 
 
 
 
 
Fig. 23. Contrast sensitivity measured by means of a Prusky water maze. Stimuli were 
gratings of decreasing contrast, fixed frequency of 0.117 cycles/degree and fixed 
luminance of 39.95 candels/m2 . At P45, P60 and P90, contrast sensitivity was higher (and 
therefore the minimum contrast detected lower) in EE as compared to ST rd10 mice. The 
sensitivity of wt animals is obviously even higher. Student t test. ***: p<0.001. 
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5.2 EE might change the expression of specific mRNAs in retinas of 
adult rd10 mice: preliminary data 
 
Numerous studies suggest that retinal neurons have an endogenous 
mechanism of protection from chronic injury and genetic degeneration. For 
example, mild light stress has been shown to induce endogenous protection of 
photoreceptors from a subsequent light damage, and protection coincided with 
prolonged up-regulation of neurotrophic factors (Liu et al. 1998). Indeed, 
bFGF mRNA expression was up-regulated in mice homozygous for the rd1 
mutation in the PDE6b gene (a model of Retinitis pigmentosa whit a faster 
photoreceptor degeneration than our model) (Gao and Hollyfield 1995). 
Elevated levels of retinal bFGF or CNTF expression, but not of BDNF 
expression, were also found in light-induced as well as inherited models of 
photoreceptor degeneration in both mice and rats (citare). These studies report 
that contrary to the initial working hypothesis, a reduction in BDNF levels 
resulted in photoreceptor protection against light damage. Survival was 
paralleled by a reduction in oxidative stress and the preservation of 
neurotrophin levels, suggesting that chronic reduction of BDNF in the retina 
provides a level of preconditioning against stress (Gao and Hollyfield 1996; 
Wen et al. 1998). Collectively, these studies demonstrate that stress in the 
retina caused by light, mechanical injury, and genetic mutations can induce 
endogenous up-regulation or modification of neurotrophic factors. Regulation 
of these factors is likely functional, since a number of studies have shown that 
injection or viral-mediated expression of these factors can protect 
photoreceptors (LaVail et al. 1992; Sieving et al. 2006). 
 All together our results point to the effectiveness of EE in extending the 
time window during which rd10 mutant mice can effectively see. In order to 
test the hypothesis that EE promotes production and release of neurotrophic 
factors in the retina, we measured by qRT-PCR retinal mRNA for the 
neurotrophins already known to promote survival of photoreceptors.  
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In our preliminary studies we did not find any major change in gene 
expression for BDNF and NGF between EE and age-matched ST mice. Data 
appear variable from sample to sample and this might reflect a true biological 
difference among different animals, as well as the combination of factors 
running out at a given age (photoreceptor death, reactive gliosis, completion 
of of retinal development). However, we found a down regulation of CNTF in 
EE mice at P13. Such down regulation does not appear to extend to adult life, 
when CNTF mRNAs becomes similar in EE and ST retina mice (Fig. 24).  
 
 
 
 
 
 
 
 
Fig. 24. Relative amounts of mRNA for CNTF, BDNF and NGF detected by qRT-PCR in 
retinal extracts from rd10 mice raised in ST (black bars) and EE (red bars) at 3 different 
ages. Rq values (referred to GADPH mRNA taken as reference value) in EE were 
normalized to those of ST. CNTF mRNA significantly higher at P45 and P60.  
 
 Building a time-course diagram of gene expression for BDNF, NGF 
and CNTF reveals an effect of EE on neurotrophin gene expression. Indeed, 
as it is shows in Fig .25, there is a clear and selective down regulation of 
BDNF mRNAs in EE retinas during the period P13-P45-P60, with respect to 
the expression in ST retinas. Comparing the two types of treatment (EE vs. 
ST) by means of ANOVA two way test, we found a statistically significant 
difference (P=0.036) between the mean of ST retina extracts and the mean of 
EE retina extracs. CNTF mRNAs expression in EE appears to move in a 
reverse way respect to ST (Fig. 25). At least NGF mRNAs expression does 
not seem to be affected by EE treatment during the time window considered. 
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Fig. 25. Relative amounts of mRNA for CNTF, BDNF and NGF detected by qRT-PCR in 
retinal extracts from rd10 mice raised in ST (black ) and EE (red ) during 3 different ages. 
Rq values (referred to the mean of GADPH mRNA mean at 13 days of life taken as 
reference value) in EE were normalized to those of ST. There is a statistically significant 
difference in BDNF mRNAs expression between ST and EE treatments during the time 
point analyzed. ANOVA two way *p= 0,036. 
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5.3 Long term effects of EE  
 
The results reported in this thesis reveal that early exposure to EE is a 
powerful tool able to expand the window of cone viability during the peak of 
rod degeneration rate and afterward. One main purpose of this thesis is to 
assess if EE can delay the degeneration, in particularly of cones, even in the 
long run, also in perspective of cures for human RP requiring cone 
maintenance. Thus, we allowed a group of rd10 mice born and raised in 
enriched conditions to stay under EE until reaching one year of age. Then, we 
started analyzing retinal morphology in these animals, comparing it to that of 
age-matched rd10 mice always kept in ST conditions. On the same groups of 
animals, we also performed behavioral experiments to determine visual 
acuity. 
 Low magnification fluorescence microscopy of whole mount retinas, 
again immunostained with cone-specific opsins for S and M/L cones, did not 
show apparent differences between retinas of EE and ST mice at one year of 
age. However, cone counting revealed that, even if a continued decline in the 
number of residual cones was present both in EE and in ST mice, rd10 EE 
mice of 1 year showed almost three times as many surviving cones 
(34000±4000) than ST control mice (12700±1800)t-test **p=0.003 (Fig. 26). 
Moreover, although cone remodeling proceeded in both groups of animals in 
the same way demonstrated in literature (Lin et al. 2009), in EE retinas 
residual cones retained a form more reminiscent of their original shape, with 
clear remnants of outer segments. Electron microscopy analysis is 
programmed to confirm this point. 
 To look through the morphology of the inner retina, we analyzed again 
the distribution of different markers such as PKC α (for rod bipolar cells) and 
Calbindin D (for horizontal and amacrine cells), comparing retinal sections of 
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rd10 mice kept in EE condition or in ST condition at 1 year of age. We did 
not detect any difference (Fig. 27).  
And yet, at 1 years of age, EE mice are still capable to perform the visual 
water task. This demonstrated that EE mice at 1 years of age still conserv a 
residual visual acuity (0,2 c/dg) that is virtually absent in ST age-matched 
mice(0,06 c/dg) (Fig.28). 
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Fig. 26. Two examples of retinal morphology and survival of cones in mice raised in ST 
and EE. (A and B) Retinal whole mounts from 1 year old rd10 mice raised in ST (A) and 
EE (B), stained with antibodies against cone-specific opsins (red). A big area devoid of 
cones is evident in the central part of the retina, showing a nasal-temporal pattern of 
degeneration. Cones are still preserved in the periphery of both retinas. No major 
differences are evident. 
High-magnification confocal images of retinas stained for cone opsin from rd10 mice 
raised in ST (C: central retina and E: peripheral retina ) or in EE (D: central retina and F: 
peripheral retina) shows that 1) local density is higher in EE as compared to ST samples. 2) 
the cone remodeling typical of degeneration does occur in both cases, but 3) EE cones 
display a better morphology( both in centre and in periphery D and F) and more preserved 
outer segments in periphery (F) .  
Counts from 4 retinas of each group show that rd10 EE mice of 1 year have almost three 
times as many surviving cones (34000±4000) than ST control mice (12700±1800) t-test 
**p=0.003. 
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Fig. 27. Vertical retinal sections showing the inner retina at 1 year of age in ST mice (A 
and C) and EE mice (B and D). Starting from top: Calbindin-D-28 staining of horizontal 
cells and amacrine cells (green). Sections. Sections stained with antibodies against PKCα 
(green),labeling rod bipolar cells (rbc).  
These images do not show a difference between the two groups of animals, but again high 
magnification shows better preservation of rod bipolar dendritic trees in EE samples. 
 
 
 
 
 
 
 
Fig. 28. Visual acuity of rd10 mice 1 year hold is significantly higher in EE than in age-
matched ST tested. Student’s t test, *p=0,029. Each column shows the mean of 4 animals 
for each groups (and SEM). 
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6 DISCUSSION 
6.1 Early EE retards the onset of rod and cone loss during weaning 
 
Retinitis pigmentosa (RP) is one of the most important subtypes of inhered 
forms of blindness, actually the second main causes of hereditary blindness in 
20-64 years people (Wright et al. 2010). RP is an excellent model for diseases 
that lead to loss of vision. It has defined genetic causes and there are several 
animal models with mutations in the same genes leading to human RP. 
 In our study, we used a well know mouse model of RP, the rd10. It has 
already been shown that in the rd10 mouse, photoreceptors start to die past the 
late phases of retinal synaptogenesis (Sharma et al. 2003). Therefore, we 
analyzed the pycnotic photoreceptor profile at P24 in ST and EE retinas. We 
found that, while at this age, ST retinas go through a massive photoreceptor 
death, retinas of EE mice displayed fewer numbers of pycnotic photoreceptor 
nuclei.  
 
6.2 EE promotes cone survival in RP adult mutant animals 
 
One of the most important aspects of the RP pathology is that secondary 
degeneration of cones proceeds in parallel at a slower rate than rods and a 
scattered population of aberrant cones persists for up to at least 9 months of 
age causing a day blindness in human patients (Chang et al. 2002; Otani et al. 
2004). Electrophisiologically, ERG responses cannot be recorded after P55-
P60 (Gargini et al. 2007) ( I. Piano et all. ERM 2011, Amsterdam Settember 
22-24, 2011). Besides rod photoreceptors, that in this model carry the 
mutation and are doomed to die, our work focused on cone preservation, 
studying the effects of EE. Indeed, although no cure for RP is presently 
available, different therapeutic approaches, such as neuroprotection, promise 
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to delay the intrinsically slow degenerative process of RP by interfering with 
the death of rod and cone photoreceptors.  
Applying from birth the EE paradigm to rd10 mice we found a higher number 
of cone survival both at P45 and at P60, age in which rod are  already die out 
and also cone photoreceptor are dying. The rationale for this approach lies in 
the fact that increased rod survival extends cone viability as well (Leveillard 
et al. 2004; Lipinski et al. 2011). Given the importance that cones have for 
everyday life, and considering that as little as 10% of the total number of 
cones is sufficient for independent living in humans (Hartong et al. 2006), 
developing treatments finalized to extend the lifespan of these cells is 
particularly relevant. For that reason we decided to apply a neuroprotective 
approach that had already shown to promote plasticity in the adult nervous 
system, having remarkable effects in animal models of different CNS 
affections, the environmental enrichment (EE). EE could pave the way for 
novel therapeutic strategies for the treatment of brain injuries and 
neurological disorders in adulthood, when recovery and functional 
rehabilitation are very hard to achieve.  
 
6.2.1 Photoreceptor survival in EE: morphology 
 
Our data show that in retinas of rd10 mice born and raised in EE, the number 
of rows of surviving photoreceptors in the outer nuclear layer is higher than in 
rd10 mice maintained in ST at 45 post-natal days. At the same age in EE, but 
not ST, rod outer segments showed positive staining with antibodies against 
rhodopsin and the cGMP-gated light-sensitive channel, suggesting that these 
cells were still light responsive. Although our data show that in EE rd10 
retina several morphological modifications were detectable at 45 days of age, 
these modifications were much more limited than in rd10 ST counterparts, in 
which they became widespread at 2 months. 
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 6.2.2 Photoreceptors survival in EE: cones 
 
 It is well know that in many forms of retinal degeneration, including RP, the 
primary pathological event is rod death. In the rd10 mouse model, rods die 
because they express a missense mutation in Pde6b gene (Arg560Cys) 
(Chang et al. 2007). Afterwards, and for yet unknown reasons, cones cannot 
survive. The dynamics of this process have been already clearly explained for 
the rd1 mutant (Lin et al. 2009). These authors showed that after the primary 
death of rod photoreceptors, cones lose their outer segments and partially 
retract or lose their axon and synaptic pedicle. Until the end, they retain many 
fundamental features of the original cone phenotype, and for many weeks the 
cells also preserve their laminar position, forming a cell row just distal to a 
much thinned outer plexiform layer. The somata subsequently enlarge (Lin et 
al. 2009).  
 In our work, we assessed cone survival at 45 and 60 days of life and we 
found that at 45 days of age approximately 100,000 cones persisted in retinas 
of EE rd10 mice, instead of a mean of 83,000 cones in ST rd10 mice. The 
most exciting observation was that at P60 in control rd10 mice, an area devoid 
of cones was clearly evident in the central part of the retina, according to the 
centre-to-periphery pattern of degeneration typical of RP-like rodent retinas. 
Instead, in rd10 mice raised in EE this degeneration was much milder. At 
higher magnification, the cones in ST appeared aberrant and devoid of outer 
segments, with opsins immunoreactivity concentrated in cell bodies. In EE, 
surviving cones had normal morphology and long outer segments. We found 
approximately 95,000 cones persisting in retinas of EE at P60, corresponding 
to over 65% of the cone population of a normal mouse retina. This is a 
remarkable observation considering that only 53,000 aberrant cones (36% of 
that in wild type mice) survived in retinas from age matched control animals 
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in ST. Studying cone morphology in whole mount preparations, we observed 
that the persisting cones in EE retinas were better conserved that cones in ST 
retinas at all the age tested, strongly indicating a delay in their secondary 
remodeling and death. 
 
6.2.3 Inner retina in EE: morphology  
 
Retinal remodeling can be defined as the expression of molecular and cellular 
phenotypical changes in the neural retina in response to inherited or acquired 
degenerations of the sensory retina (Marc and Jones 2003). Degenerations in 
the mammalian retina generally progress through three phases. Phase 1 
initiates with expression of a primary insult, followed by phase 2 
photoreceptor death that ablates the sensory retina via initial photoreceptor 
stress, phenotype deconstruction, irreversible stress and cell death, including 
bystander effects or loss of trophic support. The loss of cones heralds phase 3: 
a protracted period of global remodeling of the remnant neural retina. 
Remodeling resembles the responses of many CNS assemblies to 
differentiation or trauma, and includes neuronal cell death, neuronal and glial 
migration, elaboration of new neurites and synapses, rewiring of retinal 
circuits, glial hypertrophy and the evolution of a fibrotic glial seal that isolates 
the remnant neural retina from the surviving RPE and choroid. It is important 
to remember that retinal remodeling is not a form of plasticity, but represents 
the invocation of mechanisms resembling developmental and CNS plasticity 
in order to preserve at least as possible neural function, involving changes on 
a set of inner retina cells such as bipolar cells and amacrine cells with a 
negative impact on visual recovery. 
 The effects of EE on inner retinal morphology were examined by 
immunostaining P45 and P60 retinal vertical sections with antigens specific to 
rod bipolar cells (PKCα) (Vaquero et al. 1996) and horizontal cells (Calbindin 
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D 28 K) (Lin et al. 2009). In ST retinas from both ages, regressive events 
were seen as pronounced dendritic retraction of rod bipolar cells and loss of 
bassoon immunoreactivity, a photoreceptor ribbon synapse marker (Dick et 
al. 2003). In EE retinas, rod bipolar cell dendrites were more extensively 
ramified and decorated by bassoon-positive puncta that label synaptic ribbons 
in photoreceptor terminals. Also the contours of photoreceptor endings in the 
outer plexiform layer (OPL), were more preserved in EE than in ST as it is 
show by anti-PSD95 immunolabelling. Thus, EE was effective in limiting the 
regressive remodeling of retinal neurons postsynaptic to photoreceptors that is 
typically associated with the death of these cells (Marc et al. 2003). 
 
6.2.4 Photoreceptor survival in EE: western blot. 
 
Increased survival and preservation of rods and cones in EE rd10 mice aged 
P60 was confirmed by western blot analysis. Retinal expression levels of the 
same photoreceptor specific proteins documented by immunostaining were 
higher in EE than in ST. Our experiments demonstrated that cone-Opsins 
were 20% more expressed in EE retina than in ST. Similarly, the cGMP-gated 
light-sensitive channel was 54% higher, while rhodopsin was 10% more 
expressed in EE respect to ST retinas. Thus, convergent results from different 
morphological and biochemical determinations indicate that exposure of rd10 
mice to EE is effective in preserving retinal morphology and synaptic 
connections and in extending the lifetime of retinal rods and cones. 
 
6.2.5 Retinal physiology in EE: electroretinogram recordings  
 
Electroretinogram recordings of rd10 mutant mice reared in standard 
laboratory conditions reveal alterations in the physiology of the inner retina as 
early as P18 (before any obvious morphological change of inner neurons) and 
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cannot be recorded after P55-P60 (Gargini et al. 2007) (I. Piano et all. ERM 
2011, Amsterdam September 22-24, 2011). In our studies at P45, the 
amplitude of the photopic response did not differ between EE and ST mice. 
However, at P60 and P75, photopic ERG responses at increasing flash 
luminance showed greater b-wave amplitude in EE, demonstrating a 
preservation of cone function. Thus, in EE, surviving cones were viable, 
functional and capable of generating light responses. 
 
6.2.6 Visual system physiology in EE: behavioral tests 
 
In recent studies carried out in rodents, EE turned out to be very effective for 
treating amblyopia in adulthood. A brief exposure (two to three weeks) of 
adult amblyopic rats to EE has been demonstrated to promote a complete 
recovery of visual acuity, an effect documented not only at the 
electrophysiological level, but also using behavioral assessments (Sale et al. 
2007). Encouraged by this promising results obtained with EE in rodents, we 
assessed whether the morphological, biochemical and physiological 
preservation of the retina achieved by raising rd10 mice in EE translated into 
maintained visual perception. We found that rd10 mice raised in EE had 
significantly higher VA at all adult time points tested.  
 We also measured contrast sensitivity. At P45, mice raised in ST had 
poor contrast sensitivity (requiring a minimum of 25% contrast to locate the 
platform) and this deteriorated noticeably over time to 54% at P90. Instead, 
mice raised in EE had significantly better contrast sensitivity at all three time 
points (detecting gratings with only 7% contrast at P45 and 16% at P90), 
although here too there was a deterioration with age.  
 Altogether, these results indicate a great effectiveness of EE in 
considerably extending the time window during which rd10 mice can 
effectively see. 
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 6.2.7 EE and neurotrophins mRNA expression  
 
Retinal neurons, such as all different cells in the body, have the same genome, 
that is, exactly the same DNA nucleotide-sequence, with only a few 
exceptions in the reproductive and immune systems; thus, liver cells have the 
same DNA as neurons, but how can two cells have exactly the same DNA and 
be so different? And in which specific way neurons can be different?  
One of the mechanisms that determine the amount and which gene have to be 
transcript is the regulation of gene expression.  
Gene regulation is essential as it increases the versatility and adaptability 
of an organism by allowing the cell to express protein when needed. 
Regulation of transcription is a central part of the gene expression and is 
crucial because controls when transcription occurs and how much RNA is 
created.  
A large part of this pathways in the CNS is influenced by the experience 
(Ossipow et al. 2004) and the long-term effects of EE are likely mediated by 
signaling cascades regulating experience-dependent gene transcription, and 
this has already been demonstrated in the visual system (Putignano et al. 
2007). It has been also demonstrated that Environmental Enrichment strongly 
affects visual system maturation both at retinal and cortical levels, enhancing 
neurotropic factor expression (Landi et al. 2009). To determine whether the 
effects on cone survival in retina of EE mice were modulated by increased 
production of neurotrophins, we measured levels of BDNF, NGF and CNTF 
mRNAs. We did measurements on retinal extraction of EE and ST animals at 
P13, P45 and P60. In our preliminary studies, we did not find difference in 
relative levels of all mRNAs tested between mice raised in ST and EE at all 
ages tested. The only noticeable observation was that CNTF mRNAs are very 
variable over time, with a higher intrinsic variability is ST samples. Also, 
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there was a small decrement of CNTF mRNAs in EE retinas at P13 (day when 
ST mice open their eyes and two days after EE eye opening), this data have to 
be confirmed.  
However, performing a time-course analysis of the relative gene 
expression using as a reference the mean of ST P13 housekeeping gene value, 
we noticed that there was a different modulation of BDNF and CNTF 
mRNAs expression in EE retinas during the time course of retina 
development. In particular, there was a down regulation of BDNF during 
youth in EE retinas with respect to ST retinas (P13); also, there was an 
inversion of CNTF relative levels of expression between EE and ST retinas in 
the same time window.  
While also these data have to be confirmed, the very fact that only CNTF 
mRNA is highly variable between the animals from the same group supports 
the idea that CNTF could be one of the EE effectors and itself, or some 
molecules that could interact with, influence cone survival and that this factor, 
alone or in combination with other neurotrophins, might have beneficial 
effects on the survival of these cells (LaVail et al. 1992; LaVail et al. 1998; 
Sieving et al. 2006).  
 There is also evidence that (presumably through Muller cells) a feed-
forward loop exists between low levels of BDNF (Wilson et al. 2007) and an 
increase of CNTF (Wilson et al. 2007) or bFGF (Wilson et al. 2007) in retinas 
exposed to light damage. Indeed, BDNF levels lower than normal mimic a 
protection of photoreceptors cells similar to a preconditioning in light damage 
retinas (Wilson et al. 2007). This may be what happens in EE retinas that are 
most durable in terms of secondary degeneration of cones. If confirmed, this 
could be another proof that BDNF is one of the executors of EE effects.  
 Other recent studies enhance the fact that CNTF during retinas 
development could change the fate of photoreceptors, promoting the 
development of S-cone opsins instead of rod-opsin (Rhee and Yang 2010). 
These findings are in line whit the hypothesis formulated by Landi et al. that 
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underlines the role of IGF1 in EE effects during retinal development (Landi et 
al. 2007; Landi et al. 2009). Both IGF1 and CNTF stimulate phospho Inositol 
3 phosphate (PI3K), which, in turn, modulates different growth factor 
receptors and is downstream of the insulin receptor, but upstream of mTOR 
kinase activity (Punzo et al. 2009) (Fig. 29).  
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Fig. 29. The mTOR pathway is regulated by a wide variety of cellular signals, including 
Mitogenic Growth Factors, Hormones such as Insulin, Nutrients (Amino acids, Glucose), 
Cellular Energy Levels, and Stress conditions. A principal pathway that signals through 
mTOR is the PI3K/Akt (v-Akt Murine Thymoma Viral Oncogene Homolog-1) signal 
transduction pathway, which is critically involved in the mediation of cell survival and 
proliferation. Signaling through the PI3K/Akt pathway is initiated by mitogenic stimuli 
from growth factors that bind receptors in the cell membrane. These receptors include 
IGFR (Insulin-like Growth Factor Receptor), PDGFR (Platelet-Derived Growth Factor 
Receptor), EGFR (Epidermal Growth Factor Receptor). The signal from the activated 
receptors is transferred directly to the PI3K/Akt pathway, or, alternatively, it can be 
activated through activated Growth Factor Receptors that signal through oncogenic Ras. 
Ras is another central switch for signal transduction and has been shown to be a pivotal 
activator of the MAPK (Mitogen-Activated Protein Kinase) signal transduction pathway. 
PI3K/Akt pathway can also be activated by Insulin via IRS1/2 (Insulin Receptor Substrate-
1/2). Insulin binding activates the IR (Insulin Receptor) tyrosine kinase, which 
phosphorylates IRS1 or IRS2. PI3K binds phosphorylated IRS by SH2 (Src-Homology-2) 
domains in the p85 regulatory subunit. This interaction activates the p110 catalytic subunit. 
PI3K then catalyzes the conversion of membrane-bound PIP2 (Phosphatidylinositol (4,5)-
bisphosphate) to PIP3 (Phosphatidylinositol (3,4,5)-triphosphate). PIP3 then binds the 
pleckstrin homology domain of Akt, which results in Akt activation through dimerization 
and exposure of its catalytic site. Akt can also be phosphorylated and activated by PDK-1 
(Phospholipid-Dependent Kinase-1). Akt phosphorylates mTOR directlyRHEB-GTP 
activates mTOR. PMA (Phorbol Myristate Acetate) can also lead to mTOR 
phosphorylation independently. From Sabioscience. 
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6.3 EE effects endure in the retinas of aged mutant animals 
 
6.3.1 Photoreceptors survival in 1 year old EE mice: cones 
 
There are many articles dedicated to study the effects of EE during different 
stages of life. Some of them highlight the fact that these effects are only 
transient both in healthy and diseased brains; others indicate that if the 
enrichment is prolonged it does ameliorate the outcome of some pathologies 
(van Praag et al. 2000; Pizzorusso et al. 2007; Spolidoro et al. 2009). 
 In our case, we found that, mice born and maintained in EE for a 
lifetime showed a larger number of surviving cones than mice that spent all 
their life in ST conditions. Furthermore, in EE retinas cones appeared less 
modified than in ST retinas, having a better preservation of shape and 
presumptive outer segment and showing a smaller cell body with respect to 
cones in ST retinas. 
 This observation point out the fact that EE have durable effects on 
cones avoiding that these cells die . 
  
6.3.2 Inner retina in old EE: morphology 
 
There is no evidence of an effect of EE on inner retinal morphology. Rod 
bipolar cell are remodeled and with scant dendrites in both EE and ST retina 
from 1 year old mice. No difference is shown also in immunostaining for 
horizontal cells. This lack of effects may be due in part to the fact that the 
inner retina is quite degeneration-resistant and that remodeling is brought to 
light only buy extensive cell characterization and counting. We used a limited 
number of markers as the study of the morphology of other retinal neurons 
(i.e. cone bipolar cells, ganglion cells) was beyond the scope of this thesis.  
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 6.3.3 Visual system physiology in old EE: behavioural test 
 
 Visual Acuity (VA) is a parameter directly linked to the spatial resolution of 
the visual processing system and the decay of VA represents the first problem 
for RP patients since it is directly connected to a non autonomous life. Thus 
far there were few therapies able to slow down the loss of visual acuity in RP 
patience for that reason we consider a very important result the finding that 1 
year old EE mice retain a minimum VA and that at this age they are still able 
to perform the task, unlike age matched ST mice. 
 95
7 CONCLUSIONS AND SPECULATIONS 
 
In RP, photoreceptors are condemned to death and therefore blindness is the 
inevitable outcome. So far, no treatment other than replacing, when possible, 
the defective gene can definitely stop the progression of this disease. In the 
present Thesis, we performed a multidisciplinary study on a mouse model of 
RP, applying the paradigm of Environmental Enrichment (EE), in which mice 
are born and raised under conditions that stimulate voluntary motor activity, 
sensory experience and social interactions. This non-invasive physiological 
manipulation produced remarkable therapeutic effects on the visual system by 
significantly extending the time during which rd10 mice, doomed to early 
blindness, maintained good visual functions.  
 All measurements carried out to test the effects of EE were consistent 
in showing significant retinal preservation. Morphological studies 
documented an increased photoreceptor survival, long lasting maintenance of 
rod and mainly of cone integrity and preservation of their connectivity; ERG 
recordings confirmed retention of retinal capability to respond to light in adult 
age; visual acuity, which is set by the cone density and which we measured in 
a behavioral task, confirms preservation of retinal cones; finally, contrast 
sensitivity, which reflects the integrity of the overall neuronal processing of 
visual signals, demonstrates conserved visual function over time in EE mice. 
Thus, in agreement with the latest results obtained for other CNS pathologies, 
EE also seems to have substantial benefits on inherited retinal degeneration 
introducing a postponement in the unavoidable photoreceptor death.  
 The rescue effects of EE are both powerful and long lasting over animal 
life. We can speculate that EE acts by up regulating retinal self-defense 
mechanisms. Indeed in diseased retinas, several tropic factors (e.g. CNTF, 
FGF-2 ) are chronically up regulated (Wilson et al. 2007) (Gargini et al. 2004) 
and are also important for a better preservation of photoreceptors in culture 
(Lipinski et al. 2011). The major local sources of tropic molecules are Muller 
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cells, astrocytes, activated microglia, and the retinal pigment epithelium 
(Harada et al. 2002; Harada et al. 2003; Gargini et al. 2004; Ming et al. 2009). 
Regulation of trophic factors and the feed-forward between the different 
molecules is an homeostatic response probably enhanced by both the disease 
itself and EE, as suggested by the decreased levels of CNTF found here at 
P13, before the acute phase of photoreceptor degeneration. Indeed, it is 
reported that ERG detects signs of physiological alterations in rd10 retinas 
before manifest signs of major photoreceptor death (Gargini et al. 2007). 
Later, at P45, CNTF mRNA was relatively higher in EE versus ST mice. This 
could reflect a difference in the response to the pathology in EE individuals. 
CNTF is the most effective of all factors tested for the ability to protect 
photoreceptors in a large variety of retinal diseases (Sieving et al. 2006).  
 Certainly the change of expression in CNTF mRNAs is not the only 
downstream effect of EE. Another mechanism through which EE could exert 
its effects is the increased production of insulin-like growth factor 1 (IGF-1) 
in healthy pup retina. Sale and collaborators measured enhanced levels of 
IGF1 in the milk of enriched rodent mothers and hypothesized that this 
molecules mediates the effects of EE on retinal and cortical development. 
These and other studies report that EE outcome is mediated also by BDNF, 
which has different effect on the visual system in development versus 
adulthood (Landi et al. 2007; Sale et al. 2007; Landi et al. 2009). It has also 
been shown that insulin, which shares receptors and largely overlapping 
signaling pathways with IGF-1 (Denley et al. 2005), protects photoreceptors 
(and cones in particular) from degeneration, by activating the insulin-mTOR 
pathway and reducing the shortage of glucose that leads to the starvation of 
these cells (Punzo et al. 2009). In turn, it is known that the mTOR pathway is 
based on a classic survival kinase that links extracellular tropic/growth factors 
with intracellular antiapoptotic pathways named phosphoinositide 3-kinase 
(PI3K) (Ivanovic et al. 2011). For these reasons, it is possible that in EE both 
a direct action on cones of various up regulated molecules and an indirect 
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effect of rod-mediated survival contribute to increased cone lifespan. The 
beneficial effects of EE on vision are also likely to involve not only retinal 
changes, but other visual areas of the brain including the cortex. Indeed our 
results regarding the preservation of visual acuity in one year old EE mice 
could be mediated also by an increased neural response of visual cortex as is 
already demonstrated in other rodent models (Sale et al. 2007; Baroncelli et 
al. 2010). 
 The non-invasive nature of EE makes this therapeutic approach 
particularly eligible for human application. Given the efficacy of EE as a 
method to promote CNS plasticity and repair in general, and the results 
reported here on inherited retinal degeneration, manipulation of the external 
milieu could be considered a promising strategy to delay symptoms in patients 
with RP that are waiting for a decisive remedy. Translation of EE from the 
laboratory to the community could involve recommending healthy life styles, 
regular physical exercise and frequent social interactions, often sacrificed by 
limitations imposed or associated with visual impairment in these patients. 
Although most persons live in complex environments and commonly 
experience novelty, the exposure to cognitive, social and physical stimulation 
is highly variable among individuals and, for a single person, changes 
throughout the course of a lifetime. Moreover, it should be considered that EE 
favors stress-free and challenge-free interactions in a stimulating surrounding 
that might enhance self-defense responses of the body to disease (Cancedda et 
al. 2004; Sale et al. 2004). We hope that the results reported here should 
encourage the exploration of application of EE paradigms, alone or in 
combination with pharmacological approaches, for the therapy of RP. 
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